American College of Clinical Pharmacy
      Search      Cart
         
PRN Report

PRN News Briefs

Adult Medicine PRN

Promotions

  • Jimmy Gonzalez: Clinical Associate Professor, Rutgers University, Ernest Mario School of Pharmacy.
  • Haley N. Johnson: Associate Professor, Pharmacy Practice; St. Louis College of Pharmacy at University of Health Sciences and Pharmacy.
  • Toby Trujillo: Vice Chair of Clinical Programs for the Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences.
  • Jon P. Wietholter: Chair, Clinical Pharmacy Department, West Virginia University School of Pharmacy.

 Awards

  • Alexa Carlson: 2025 Preceptor of the Year Award, Massachusetts Society of Health-System Pharmacists.
  • Cait Gibson: Bertha Rolfe Teacher of the Year Award, Virginia Commonwealth University School of Pharmacy.
  • Taylor Steuber: 2024 AACP Curriculum SIG Publication Award.
  • Andrew Stone: Preceptor of the Year, OSU Pharmacy Residency Programs.
  • Jon P. Wietholter: P3 Teacher of the Year, West Virginia University School of Pharmacy.

 Grants

  • Cait Gibson: Characterization of First-Generation Pharmacy Student Experiences: A Multi-school Qualitative Study. From First-Generation and AAPI Student Success Grant, You First at VCU First-Generation Student Success and Research Center. Primary Investigator ($6946.45).

 Publications

  • Campbell N, Kalabalik-Hoganson J. Accuracy and teachability of artificial intelligence chatbots in solving pharmaceutical calculations: a descriptive study. Int J Clin Pharm. 2025;47(4):1109-1113. https://doi.org/10.1007/s11096-025-01947-7
  • Han J, Fang Y, Campbell N. Real-world safety profile of lecanemab: disproportionality analysis of adverse reactions in the FDA Adverse Event Reporting System (FAERS). JAPhA Pharmacother. 2025;2(2):100015. https://doi.org/10.1016/j.japhar.2025.100015
  • Burchette JE, Covert K, Tu P, White BP, Chastain DB, Cluck DB. Pivmecillinam for uncomplicated acute cystitis: a contemporary review. Ann Pharmacother. 2025;59(8):743-757. https://doi.org/10.1177/10600280241288554
  • Chastain DB, Cluck DB, Covert KL. Bacteremia and infective endocarditis. In: Haines ST, Nolin TD, Ellingrod VL, Posey L, Cochoba J, Holle L, eds. Pharmacotherapy: A Pathophysiologic Approach. 13th ed. McGraw-Hill; 2025.
  • Lanier C, Brumit JC, Tharp J, Crawford J, White KM, Wilson V, Covert K. Incidence and potential predictors of SGLT2 inhibitor initiation in acutely hospitalized patients with heart failure. Am J Health Syst Pharm. 2025;82(13):e624-e631. https://doi.org/10.1093/ajhp/zxaf025
  • Gibson CM, Desai UR, Wesling ME. Factor XI/XIa inhibitors: a potential solution to anticoagulation dilemmas. Expert Opin Pharmacother. 2025;26(5):605-616. https://doi.org/10.1080/14656566.2025.2475192
  • Gibson CM, Escaño AK, McKenzie JJ, Wijesinghe DS, Donohoe KL. Enhancing student knowledge and confidence through two sequential total parenteral nutrition active learning approaches. Curr Pharm Teach Learn. 2025;17(9):102396. https://doi.org/10.1016/j.cptl.2025.102396
  • Haines SL, Lee KC, Gable KN, Thigpen J, Gibson CM, Morley S, et al. Exploration of psychosocial hazards: core values, justice and fairness, and social support to address workforce well-being. Am J Pharm Educ. 2025;89(8):101460. https://doi.org/10.1016/j.ajpe.2025.101460
  • Mnatzaganian CL, Gibson CM, Kipper L, Williams CR, Cat TB. The preceptors’ toolkit for working with struggling pharmacy students. Pharmacy (Basel). 2025;13(3):66. https://doi.org/10.3390/pharmacy13030066
  • Acbo A, Nissim YC, Waterloo M, Ismail O, Gonzalez J. The impact of hypoalbuminemia on antibiotic therapeutic outcomes: a focused review. Curr Pharmacol Rep. 2025;11:16. https://doi.org/10.1007/s40495-025-00397-z
  • Brust-Sisti L, Hu GY, Bridgeman M, Brunetti L, Gonzalez J. Comparative efficacy of high- and low-dose ceftriaxone regimens: a systematic review and meta-analysis. Ann Pharmacother. 2025 Jul 27. [Epub ahead of print]. https://doi.org/10.1177/10600280251346777
  • Mamillapalli L, Lu S, Witkin J, Gavaskar R, Cheng A, McIntyre K, Aboujaoude ER, Gonzalez J, et al. A review of neonatal selective serotonin reuptake inhibitor withdrawal syndrome. J Pediatr Pharmacol Ther. 2025;30(3):323-331. https://doi.org/10.5863/JPPT-24-00010
  • Khan RW, St. Peter WL. Comment on “Establishing discordance rate of estimated glomerular filtration rate between serum creatinine-based calculations and cystatin-C-based calculations in critically ill patients.” Pharmacotherapy. 2025;45(7):468-469. https://doi.org/10.1002/phar.70034
  • Pincus KJ, Khan RW. Chapter 100: Thyroid disorders. In: Haines ST, Nolin TD, Ellingrod VL, Posey L, Cocohoba J, Holle L, eds. Pharmacotherapy: A Pathophysiologic Approach. 13th ed. McGraw-Hill; 2025.
  • Steuber TD, Trujillo D, Kleppinger EL, Andrus MR, Pinner NA, Hornsby L, et al. Impact of curricular content reduction on student-reported mental and physical health. Am J Pharm Educ. 2025;89(3):101367. https://doi.org/10.1016/j.ajpe.2025.101367
  • Salvatore D, Moore J, Steuber TD. Long-acting lipoglycopeptides compared to standard-of-care for the treatment of complicated gram-positive infections: a systematic review and meta-analysis. Int J Antimicrob Agents. 2025;66(5):107581. https://doi.org/10.1016/j.ijantimicag.2025.107581
  • Thayer B, Steuber TD, Rydz A, Fleming J, Sorenson J, Arnold M, et al. Navigating therapeutic drug monitoring of isavuconazole in invasive mold infection on extracorporeal membrane oxygenation—a case report. Innov Pharm. 2025;16(2):Article 6542. https://doi.org/10.24926/iip.v16i2.6563

 Presentations

  • Nicole Campbell:
    • Advancing medication safety: key updates from ISMP’s Best Practices for 2024-2025. Presented at: 2025 Joint March Conference presented by NJPHA and GSPO; March 2025; St. Elizabeth University; Morristown, NJ.
    • Toolkit for contraceptive care: a guide to hormonal contraceptives. Presented at: 1st Annual APN Pharmacology Day to Advanced Practice Nurses; March 2025; Seton Hall University; Nutley, NJ.
  • Andrew Stone: Don’t go breaking my heart: a cardio-oncology primer. Presented at: OSUWMC Professional Development Series; June 2025; Columbus, OH.

 New ACCP Fellows

  • Rachel W. Khan

 Other Notable Achievements

  • Rachel W. Khan:
    • Khan RW, Downes E. Green house region: tubular toxins versus oxalate offenders. NephMadness 2025 AJKDblog. Posted March 1, 2025.
    • Vinnikova A, Khan R, Downes E, King J. Leafy greens & injured beans: nature’s nephrotoxins. Episode 36. The Poison Lab Podcast. Published March 1, 2025.
  • Toby Trujillo: Elected as President-Elect for ACCP.

Ambulatory Care PRN

Promotions

  • Amanda Morrill: Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences.
  • Ann Philbrick: Professor, University of Minnesota College of Pharmacy.
  • Marissa C. Salvo: Clinical Professor of Pharmacy Practice, UConn School of Pharmacy.

Grants

  • Sharmon P. Osae: 2025 Georgia Healthy Family Alliance Community Health Grant Award. July 2025 to July 2026. Co-Principal Investigator ($5000).

Publications

  • Billups SJ, Daffron A, Harty C, Lowe RN, Lobo I. Centralized outreach with embedded pharmacist e-consultation to reduce therapeutic inertia and improve blood pressure control. Am J Health Syst Pharm. 2025 Apr 25. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxaf096
  • Virrueta NA, Valdiviez V, Beutel T, Titus OJ, Peauroi S, Billups SJ. Pharmacist-supported electronic outreach to address medication nonadherence in Medicare Advantage enrollees. J Manag Care Spec Pharm. 2025;31(1):33-41. https://doi.org/10.18553/jmcp.2025.31.1.33
  • Worledge E, Billups SJ, Titus OJ, Saseen JJ. Achievement of low-density lipoprotein cholesterol thresholds in very high-risk atherosclerotic cardiovascular disease. J Clin Lipidol. 2025 Apr 11. [Epub ahead of print]. https://doi.org/10.1016/j.jacl.2025.04.186
  • Hanson T, Paloucek F, Elmes-Patel AT. Comment: Safety of phenobarbital versus benzodiazepines for alcohol withdrawal in critically ill patients with primary neurologic injuries. Ann Pharmacother. 2025 Jul 5. [Epub ahead of print]. https://doi.org/10.1177/10600280251351934
  • Harrigfeld S, Elmes-Patel AT. Comment on “Real‐world observations of using compounded GLP‐1 ± GIP agonists within a clinical pharmacist‐managed cardiometabolic clinic.” J Am Coll Clin Pharm. 2025;8(6):515-516. https://doi.org/10.1002/jac5.70047
  • Jarrett JB, Elmes-Patel AT, Allen S, Djuric Kachlic M, Schriever A, Driscoll T, Tekian A, Cheung J, Podsiadlik E, Haines ST, Schwartz A. Longitudinal preceptor assessment of entrustable professional activities across introductory and advanced pharmacy practice experiences. Pharmacy (Basel). 2025;13(3):72. https://doi.org/10.3390/pharmacy13030072
  • Laub MP, Conway P, Trzebinska D, Wargo R, Condon Martinez AJ. The pharmacist’s role in transforming nephrology care. Am J Health Syst Pharm. 2025;82:672-680. https://doi.org/10.1093/ajhp/zxaf048
  • Ammar A, Edwin S, Whitney R, Lipari M, Giuliano C. Updates in chronic kidney disease management: a systematic review. Pharmacotherapy. 2025;45(5):291-306. https://doi.org/10.1002/phar.70014
  • Martirosov AL, Abdalla M, Fleischman M, Foster B, Gonzales J, Lipari M, et al. Navigating the alphabet soup of interstitial lung diseases (ILD): the role of pharmacists. J Am Coll Clin Pharm. 2025 Jul 27. [Epub ahead of print]. https://doi.org/10.1002/jac5.70089
  • Chow TG, McDanel DL, Turner NA, Copaesco AM. Non-allergist delabeling—should penicillin allergy delabeling only be performed by allergists? J Allergy Clin Immunol Pract. 2025;13:1011-1017. https://doi.org/10.1016/j.jaip.2024.11.028
  • Godfrey K, McDanel D, Percival K, Bowdler NC, Santillan D, Dowden AM. Screening for penicillin allergy in obstetric patients to optimize guideline directed therapy. Antimicrob Steward Healthc Epidemiol. 2025;5(1):e125:1-7. https://doi.org/10.1017/ash.2025.10033
  • Schneider B, Percival K, Rhinehart A, Frye J, McDanel D, Bebout K, et al. Assessing the safety of increased outpatient cephalosporin use following the modification of penicillin allergy cross-reactivity alerts. Infect Control Hosp Epidemiol. 2025;46:416-421. https://doi.org/10.1017/ice.2025.9
  • Salvo MC, Polomoff C. Osteoporosis. In: Sanoski CA, Witt DM, eds. Pharmacotherapy Self-Assessment Program, 2025 Book 2. Geriatrics. American College of Clinical Pharmacy; 2025:1-28.
  • Sobieraj DM, Wheeler K, Salvo M, Smith M. Prescription for curricular revision: application of design thinking principles. Am J Pharm Educ. 2024;88(12):101325. https://doi.org/10.1016/j.ajpe.2024.101325
  • Wardwell B, Salvo M. Exploring glucagon-like peptide-1 receptor agonist (GLP-1 RA) use in patients with cirrhosis. AmbCare Connect. July 2, 2025.
  • Yik R, Salvo MC. Pharmacy technician education and training: highlighting the partnership among a state pharmacy association, local community college, and healthcare system. Am J Health Syst Pharm. 2025;82(16):915-920. https://doi.org/10.1093/ajhp/zxae410
  • Claus LW, Auten M, Saseen JJ, Billups SJ. Effectiveness and utilization of xanthine oxidase inhibitors in primary care. J Manag Care Spec Pharm. 2025;31(9):1-6.
  • Schumacher C. Why I became a diabetes care and education specialist? ADCES Pract. 2025;13(1):32-33.
  • Schumacher C, Duru OK, Maripuri S, Roberts G, Van Dril E. The pharmacist as a key member of the kidney care team. Am J Health Syst Pharm. 2025;82(12):633-634. https://doi.org/10.1093/ajhp/zxaf050
  • Clements J, Schumacher C. Pharmacists in diabetes management: enhancing patient care through practice, education, and advocacy. J Am Coll Clin Pharm. 2025;8(2):74-76. https://doi.org/10.1002/jac5.2077
  • Eagan K, Bolch C, Van Dril E, Schumacher C. Changes in serum potassium in people with type 2 diabetes taking sodium-glucose co-transporter-2 inhibitors. Pharmacotherapy. 2025;45(4):194-202. https://doi.org/10.1002/phar.70006
  • Coffee AN, Smith Marsh D, Elmes-Patel AT. Additional comment on “Pharmacist-managed diabetes care and change in A1C: a retrospective matched cohort study.” J Am Coll Clin Pharm. 2025;8(4):320. https://doi.org/10.1002/jac5.70029
  • Stranges PM, Adams KK, Alharir A, Burnam LG, Elmes-Patel AT, Greenlee SB, Infante AF, Kerins A, Ma Q, Meyenburg LK, Nyman C, Peters GL, et al. Pharmacists’ contributions to the management of opioid use disorder. J Am Coll Clin Pharm. 2025;8(6):500-510. https://doi.org/10.1002/jac5.70049
  • Wheeler SE, Williamson L, Sanders K. Impact of a virtual escape quest pharmacy recruitment activity for high school students. Am J Pharm Educ. 2025;89(8):101469. https://doi.org/10.1016/j.ajpe.2025.101469.

Presentations

  • Sarah Billups:
    • Making patients healthier one millimeter of mercury at a time. Presented at: Tennessee Heart Health Learning Collaborative Webinar; July 29, 2025; virtual.
    • Revenue strategies: value-based revenue, billing for Medicare Advantage plans and incident-to billing. Presented at: American College of Clinical Pharmacy Ambulatory PRN Clinical Advancement Webinar Series; July 9, 2025; virtual.
  • Abigail Elmes-Patel: Patient factors associated with hospital discharge on buprenorphine versus methadone. Presented at: American Society of Addiction Medicine Annual Meeting; April 2025; Denver, CO.
  • Marissa Salvo:
    • The power of design thinking in curricular assessment and revision. Presented at: AACP Annual Meeting; July 2025; Chicago, IL.
    • Improving microalbuminuria screening and guideline-directed therapy for chronic kidney disease in patients with and without type 2 diabetes mellitus. Presented at: UConn Health Annual Dean’s Symposium on Quality Improvement; June 2025; Farmington, CT.
    • Impact of pharmacist intervention on increasing adult HPV vaccination rate in an outpatient internal medicine clinic. Presented at: ASHP Midyear Clinical Meeting; December 2024; New Orleans, LA. Encore presented at: New England Institute of Ambulatory Care Pharmacists Meeting; January 2025; virtual.
  • Christie Schumacher:
    • Cardiovascular-kidney-metabolic (CKM) syndrome: can we prevent progression? Presented at: Texas A&M University 19th Annual Diabetes Conference; July 2025; Corpus Christi, TX.
    • Using continuous glucose monitoring to advance cardiometabolic kidney care. Presented at: Association of Diabetes Care & Education Specialists Minnesota Coordinating Body Spring Meeting; April 2025; Minneapolis, MN.
  • Sarah Wheeler:
    • Protect and preserve kidney function: a DCES guide to CKD management in people with diabetes. Presented at: Association of Diabetes Care & Education Specialists Annual Conference; August 2025; Phoenix, AZ.
    • Maximize motivation: a motivational interviewing toolkit. Presented at: Association of Diabetes Care & Education Specialists Annual Conference; August 2025; Phoenix, AZ.

New ACCP Fellows

  • Sarah J. Billups
  • Melissa Lipari

Other Notable Achievements

  • Marissa C. Salvo: Appointed Member-at-Large, APhA Pharmacist Community.

Cardiology PRN

Promotions

  • William Baker: Professor with Tenure, UConn School of Pharmacy.
  • Alisa Escano: Associate Professor, VCU School of Pharmacy.

Awards

  • Cait Gibson: Virginia Commonwealth University School of Pharmacy Bertha Rolfe Teacher of the Year Award.
  • Alejandro Perez: American College of Clinical Pharmacy Cardiology PRN Travel Award (Resident).

Publications

  • Baker WL, Moore TE, Baron E, Kittleson M, Parker WF, Jaiswal A. A systematic review of reporting and handling of missing data in observational studies using the UNOS database. J Heart Lung Transplant. 2025;44(3):462-468. https://doi.org/10.1016/j.healun.2024.10.023
  • Jaiswal A, Baker WL, Pillai A, Kittleson M, Mogga B, Jedeon Z, et al. Corticosteroid use beyond 1-year post heart transplantation is associated with worse outcomes: a contemporary analysis of the ISHLT registry. JHLT Open. 2025;8:100214. https://doi.org/10.1016/j.jhlto.2025.100214
  • Jedeon Z, Pillai A, Baker WL, Jaiswal A. Donor pulmonary hemodynamics does not impact recipient outcomes in adult heart transplantation. Int J Cardiol. 2025;420:132747. https://doi.org/10.1016/j.ijcard.2024.132747
  • Mahajan A, Park J, Moore TE, Baker WL, Zoni CR, Akinfenwa S, et al. Generic versus brand-name immunosuppression following heart transplant: an analysis of the UNOS database. Clin Transplant. 2025;39(6):e70196. https://doi.org/10.1111/ctr.70196
  • Barry AR, Boswell R, Babadagli HE, Chen JW, Cowley E, Eberhardt TE, et al. Review of the top 5 cardiology studies of 2023-24. Can Pharm J (Ott). 2025;158(4):213-218. https://doi.org/10.1177/17151635251339445
  • Barry AR, Helisaz H, Safari A, Loewen PS. Effect of P2Y12 inhibitors on major adverse cardiovascular events after coronary artery bypass graft surgery: a population-based cohort study. Pharmacotherapy. 2025 Jul 28. [Epub ahead of print]. https://doi.org/10.1002/phar.70047
  • Flint S, Woodruff AE, Maloney M, Chilbert MR. Systematic review of venous thromboembolism (VTE) occurrence in hospitalized patients receiving prophylactic unfractionated heparin twice vs three times daily. J Thromb Thrombolysis. 2025 Jun 26. https://doi.org/10.1007/s11239-025-03137-8
  • Woodruff AE, Denny OR, Maj MS, Mills K, Chilbert MR. Readmission rates in reduced ejection fraction heart failure patients on triple guideline-directed medical therapy at hospital discharge. Ann Pharmacother. 2025 May 31. https://doi.org/10.1177/10600280251336751
  • Coons JC, Singla V, White E, et al. Anticoagulation optimization through a specialized center for atrial fibrillation. Am J Med Qual. 2025 Jun 18. [Epub ahead of print]. https://doi.org/10.1097/JMQ.0000000000000261
  • Coons JC, Wang A, Latremouille-Viau D, et al. Oral anticoagulant use among Medicare patients newly diagnosed with venous thromboembolism (VTE): factors associated with treatment status. PLoS One. 2025;20:e03211106. https://doi.org/10.1371/journal.pone.0321106
  • Ataya A, Coons JC, Patzlaff N, et al. Safety and pharmacokinetics of ralinepag, a novel oral prostacyclin receptor agonist. JHLT Open. 2025;9:100270. https://doi.org/10.1016/j.jhlto.2025.100270
  • Campbell R, Kliner J, Goetze H, Coons JC. Overcoming financial barriers to optimal guideline-directed medical therapy for patients with heart failure. JACC Case Rep. 2025;30(5):102994. https://doi.org/10.1016/j.jaccas.2024.102994
  • Deering TF, Smith AM, Gillespie JA, Simonson J, Gouveia-Pisano J, Jackson M, Blithe T, Somand H, Medico CJ, Schuleri KH, Budzyn ML, Zand R, Chaudhary D, Jain SK, Coons JC, et al. A platform designed to empower quality improvement for patients with atrial fibrillation. Am J Med Qual. 2025;40(4):156-164. https://doi.org/10.1097/JMQ.0000000000000231
  • DiDomenico RJ. Engaging in the lost art of reading: the need to connect and evolve with our learners. J Am Coll Clin Pharm. 2025;8:420-421. https://doi.org/10.1002/jac5.70044
  • DiDomenico RJ, Badowski ME, Shapiro NL, Ning J, Lee M, Wong W. Engaging pharmacy students in research and course coordination through a clinical research design elective. J Am Coll Clin Pharm. 2025;8:451-462. https://doi.org/10.1002/jac5.70030
  • Shultz B, DiDomenico RJ, Goliak K, Mucksavage J. Exploratory assessment of GPT-4’s effectiveness in generating valid exam items in pharmacy education. Am J Pharm Educ. 2025;89(5):101405. https://doi.org/10.1016/j.ajpe.2025.101405
  • Dobesh PP. Anticoagulation in ACCP Updates in Therapeutics®. The Cardiology Pharmacy Preparatory Course. American College of Clinical Pharmacy; 2025.
  • Dobesh PP, DiDomenico RJ, Rogers KC. Chapter 36: Chronic coronary disease. In: Haines ST, Nolin TD, Ellingrod VL, Posey L, Cocohoba J, Holle L, eds. Pharmacotherapy: A Pathophysiologic Approach. 13th ed. https://accesspharmacy.mhmedical.com/content.aspx?bookid=3386&sectionid=293822817
  • Dobesh PP, Volkl AA, Pap AF, Darmarju CV, Levitan B, Yaun Z, et al. Benefit-risk assessment of rivaroxaban in older patients with nonvalvular atrial fibrillation or venous thromboembolism. Drugs Aging. 2025;42:469-484. https://doi.org/10.1007/s40266-025-01192-7
  • Wenzhu L, Vedantham S, Jaffer FA, Kakkos SK, Galanaund JP, Dobesh PP, et al. Revisiting the open vein hypothesis to reduce the postthrombotic syndrome: implications for multidisciplinary care and research: a scientific statement from the American Heart Association. Circulation. 2025;151(23):e1051-e1071. https://doi.org/10.1161/CIR.0000000000001330
  • Fiuzat M, Atallah B, Page R, Vardeny O. The current landscape of training, practice, and roles of pharmacists in the field of heart failure. JACC Heart Fail. 2025;13(8):102551. https://www.jacc.org/doi/abs/10.1016/j.jchf.2025.102551
  • James JR, Fuller M, Hunt MH, Powell E, Lu G, Li Q, Omary A, Hollis IB. Hemocompatibility-related adverse events associated with or without low molecular weight heparin bridging in outpatients with a HeartMate 3 left ventricular assist device. Artif Organs. 2025;49(7):1215-1218. https://doi.org/10.1111/aor.14986
  • Gibson CM, Desai UR, Wesling ME. Factor XI/XIa inhibitors: a potential solution to anticoagulation dilemmas. Expert Opin Pharmacother. 2025;26(5):605-616. https://doi.org/10.1080/14656566.2025.2475192
  • Gibson CM, Escaño AK, McKenzie JJ, Dayanjan SW, Donohoe KL. Enhancing student knowledge and confidence through two sequential total parenteral nutrition active learning approaches. Curr Pharm Teach Learn. 2025;17(9):102396. https://doi.org/10.1016/j.cptl.2025.102396
  • Haines SL, Lee KC, Gable KN, Thigpen J, Gibson CM, Morley S, et al. Exploration of psychosocial hazards: core values, justice and fairness, and social support to address workforce well-being. Am J Pharm Educ. 2025;89(8):101460. https://doi.org/10.1016/j.ajpe.2025.101460
  • Mnatzaganian CL, Gibson CM, Kipper L, Williams CR, Cat TB. The preceptors’ toolkit for working with struggling pharmacy students. Pharmacy. 2025;13(3):66. https://doi.org/10.3390/pharmacy13030066
  • Hong Y, Hess NR, Dorken-Gallastegi A, Iyanna N, Hickey GW, Mathier MA, McNamara DM, Keebler ME, Horn ET, et al. Association of agonal phase duration with heart utilization and post-transplant outcomes in donation after circulatory death heart transplantation. J Heart Lung Transplant. 2025;44(5):736-747. https://doi.org/10.1016/j.healun.2024.11.011
  • Hong Y, Hess NR, Ziegler LA, Dorken-Gallastegi A, Abdullah M, Agrawal N, Sultan I, Horn ET, et al. Effects of ex vivo machine perfusion on preservation time and donor age in donation after brain death heart transplantation. J Heart Lung Transplant. 2025;44(5):830-835. https://doi.org/10.1016/j.healun.2024.09.012
  • Hong Y, Hess NR, Ziegler LA, Dorken-Gallastegi A, Iyanna N, Abdullah M, Horn ET, et al. Right ventricular mass oversizing is associated with improved post-transplant survival in heart transplant recipients with elevated transpulmonary gradient. J Card Fail. 2025;31(8):1152-1163. https://doi.org/10.1016/j.cardfail.2024.09.018
  • Hong Y, Iyanna N, Dorken-Gallastegi A, Nasim U, Horn ET, Mathier MA, et al. Mid-term reassessment of waitlist and posttransplant outcomes under the 2018 heart allocation system: improved all-cause survival. Circ Heart Fail. 2025 Jul 2. [Epub ahead of print]. https://doi.org/10.1161/circheartfailure.124.012663
  • Hong Y, Nasim U, Iyanna N, Dorken-Gallastegi A, Keebler ME, Horn ET, et al. Durable left ventricular assist device in donation after circulatory death heart transplantation. J Heart Lung Transplant. 2025;44(7):1011-1021. https://doi.org/10.1016/j.healun.2025.01.016
  • Iyanna N, Nasim U, Dorken-Gallastegi A, Hess NR, Abdullah M, Hickey GW, Keebler ME, Horn ET, et al. Impact of cardiopulmonary resuscitation on donation after circulatory death heart transplantation: a United Network for Organ Sharing registry analysis. J Heart Lung Transplant. 2025;44(4):594-605. https://doi.org/10.1016/j.healun.2024.11.024
  • Rivosecchi RM, Sanchez PG, Sacha LM, Horn ET, Keebler M, Silveira FP. A single center experience of concomitant administration of sofosbuvir/velpatasvir and amiodarone after heart and lung transplantation. JHLT Open. 2025;9:100279. https://doi.org/10.1016/j.jhlto.2025.100279
  • Abdel-Qadir H, Gunn M, Fang J, Odugbemi T, Jeong I, Austin PC, Dorian P, Jackevicius CA, et al. Risk for stroke after newly diagnosed atrial fibrillation during hospitalization for other primary diagnoses: a retrospective cohort study. Ann Intern Med. 2025;178(6):765-774. https://doi.org/10.7326/ANNALS-24-01967
  • Grewal K, Wang X, Austin PC, Jackevicius CA, Nardi-Admon I, Ko DT, et al. Bleeding and new malignancy diagnoses after anticoagulation for atrial fibrillation: a population-based cohort study. Circulation. 2025;151(11):773-782. https://doi.org/10.1161/CIRCULATIONAHA.124.070865
  • Khatri S, Sengul A, Moon J, Jackevicius CA. Accuracy and reproducibility of ChatGPT responses to real-world drug information questions. J Am Coll Clin Pharm. 2025;8(6):432-438. https://doi.org/10.1002/jac5.70038
  • McNaughton CD, Austin PC, Jackevicius CA, Chu A, Holodinsky JK, Hill MD, et al. Incident prescriptions for common cardiovascular medications: comparison of recent versus pre-2020 medication adherence and discontinuation in three universal health care systems. BMC Cardiovasc Disord. 2025;25(1):82. https://doi.org/10.1186/s12872-025-04492-3
  • Nakajima E, Ha ACT, Qiu F, Austin PC, Jackevicius CA, Ko DT, et al. East Asian immigration and direct oral anticoagulant dosing for atrial fibrillation: a population-based cohort study. Heart Rhythm. 2025 May 22. [Epub ahead of print]. https://doi.org/10.1016/j.hrthm.2025.05.040
  • Jacobs JA, Hendren NS, Alvarez KS, Stinson LJ, Mathew C, Harms M, et al. The effect of electronic health record choice architecture on diuretic augmentation choice. J Am Coll Clin Pharm. 2025;8(6):439-444. https://doi.org/10.1002/jac5.70028
  • Cintron MA, Baumer Y, Pang APS, Ortiz-Whittingham LR, Aquino Peterson EM, Jacobs JA, et al. Associations between the neural-hematopoietic-inflammatory axis and DNA methylation of stress-related genes in human leukocytes: data from the Washington, D.C. cardiovascular health and needs assessment. Brain Behav Immun Health. 2025 Mar 9. [Epub ahead of print]. https://doi.org/10.1016/j.bbih.2025.100976
  • Zheutlin AR, Jacobs JA, Bress AP. High-density lipoprotein cholesterol and statin use among U.S. adults with intermediate 10-year predicted ASCVD risk. JACC Adv. 2025;4(6 pt 2):101725. https://www.jacc.org/doi/10.1016/j.jacadv.2025.101725
  • Li B, Pop C, Johnson M, Sklar M, Lawler P, Elliott A. Hemodynamic effects of propofol. JACC Adv. 2025 May 14. [Epub ahead of print]. http://doi.org/10.1016/j.jacadv.2025.101769
  • Tunehag KR, Pearce AF, Fox LP, Stouffer GA, Solander S, Lee CR. CYP2C19 genotype-guided antiplatelet therapy and clinical outcomes in patients undergoing a neurointerventional procedure. Clin Transl Sci. 2025;18(1):e70131. https://doi.org/10.1111/cts.70131
  • Tisdale JE, Jaynes HA, Overholser BR, Sowinski KM, Kovacs RJ. Dihydrotestosterone pretreatment diminishes the severity of drug-induced torsades de pointes. J Cardiovasc Pharmacol. 2025 May 8. [Epub ahead of print]. https://doi.org/10.1097/FJC.0000000000001716
  • Aboshady OA, Raffa JZ, Quinney SK, Tisdale JE, Overholser BR. QTc interval changes in preeclampsia versus normal pregnancy: a systematic review and meta-analysis. Clin Pharmacol Ther. 2025;117(6):1650-1660. https://doi.org/10.1002/cpt.3605
  • Carpenter JS, Jaynes HA, Alzahrani M, Chen PS, Kovacs RJ, Tisdale JE. Palpitations in midlife women: the Menopause Racing Heart Pilot Study. Menopause. 2025;32(7):571-582. https://doi.org/10.1097/GME.0000000000002538
  • Lin S, Kote A, Andersson T, Goldhaber JI, Tisdale JE, Li X, et al. Using clonidine for neuromodulation in patients with postural orthostatic tachycardia syndrome. Heart Rhythm. 2025 May 6. [Epub ahead of print]. https://doi.org/10.1016/j.hrthm.2025.05.003
  • Liu X, Sung YL, Zhang L, Guo S, Yang M, Tisdale JE, et al. Antiarrhythmic effects of mirabegron on ventricular fibrillation in Langendorff-perfused rabbit ventricles. J Physiol. 2025;603(9):2533-2549. https://doi.org/10.1113/JP286901
  • Yeung SL, Wang M, Lou M, Ng TMH. Sodium-glucose cotransporter-2 inhibitors and ketoacidosis in heart failure: analysis of US Adverse Event Reporting System (FAERS). Eur Heart J Open. 2025;5(3):oeaf056. https://doi.org/10.1093/ehjopen/oeaf056

New ACCP Fellows

  • Ed Horn

Other Notable Achievements

  • Rob DiDomenico:
    • Elected to ACCP Board of Regents.
    • Chair-Elect, American Heart Association Council on Clinical Cardiology Clinical Pharmacology Subcommittee.
  • Josh Jacobs: Completed PhD degree in Population Health Sciences with an emphasis in Clinical and Translational Epidemiology, University of Utah.
  • Molly Kernan: BCCP.
  • Hannah Lunsford: BCCP.
  • Maria Ruiz: BCCP.
  • Katie Sandquist: BCCP.
  • Toby Trujillo:
    • Elected as President-Elect for ACCP.
    • As of July 1, 2025, will serve as Vice Chair of Clinical Programs for the Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences.
  • Ron Welch: BCCP.
  • Sarah Wong: BCCP.

Central Nervous System PRN

Promotions

  • Jason Chau: Regional Director Pharmacy Value Performance, Optum Health.
  • Van Hellerslia: Clinical Professor of Pharmacy, Temple University School of Pharmacy, Philadelphia, PA.
  • Joshua Semock: Pharmacy Residency PGY1 University at Buffalo (SUNY) and Buffalo Psychiatric Center NYS Office of Mental Health.

Awards

  • Van Hellerslia: Faculty Senate Service Award, Temple University Faculty Senate.

Grants

  • Ian McGrane: Incorporation of Electronic Prescription Claims Data Using Medicaid Web Portals and Other Commercial Sources into Medication Reconciliation at Hospitals in Montana. L.S. Skaggs Institute for Health Innovation. Principal Investigator ($25,000).

Publications

  • Hutchison LC, Sleeper RB, ed. Fundamentals of Geriatric Pharmacotherapy. 3rd ed. American Society of Health-System Pharmacists.
  • de Leon J, Baldessarini RJ, Balon R, Bilbily J, Caroff SN, Citrome L, Correll CU, Cotes RO, Davis JM, DeLisi LE, Faden J, Freudenreich O, Goldsmith DR, Gurrera R, Josiassen RC, Kane JM, Kelly DL, Keshavan MS, Laitman RS, Lam YWF, Leung JG, Love RC, McCollum B, McGrane IR, et al. Letter to the FDA proposing major changes in the US clozapine package insert supported by clozapine experts worldwide. Part I: a review of the pharmacokinetic literature and proposed changes. J Clin Psychopharmacol. 2025;45(3):179-196. https://doi.org/10.1097/JCP.0000000000001987
  • de Leon J, Baldessarini RJ, Balon R, Bilbily J, Caroff SN, Citrome L, Correll CU, Cotes RO, Davis JM, DeLisi LE, Faden J, Freudenreich O, Goldsmith DR, Gurrera R, Josiassen RC, Kane JM, Kelly DL, Keshavan MS, Laitman RS, Lam YWF, Leung JG, Love RC, McCollum B, McGrane IR, et al. Letter to the FDA proposing major changes in the US clozapine package insert supported by clozapine experts worldwide. Part II: a review of fatal outcomes in US pharmacovigilance data and proposed changes. J Clin Psychopharmacol. 2025;45(3):197-218. https://doi.org/10.1097/JCP.0000000000001990

Clinical Administration PRN

Awards

  • Tom Achey: PAI Best Practice Award Finalist, South Carolina Society of Health-System Pharmacists.
  • Gina Caliendo: Distinguished Alumnus Award, St. John’s University College of Pharmacy and Health Sciences.

 Publications

  • Achey TS. Off the clock, on purpose: sabbatical or sabotage? Am J Health Syst Pharm. 2025. In press.
  • Achey TS, Elliott SN, Harding BW, Lingenfelter EH, Ramp AM. The informed interview: a resource for pharmacy leaders. Hosp Pharm. In press.
  • Achey TS, Griffin HR. Implementation of a self-service data exploration tool within an academic medical center department of pharmacy. Hosp Pharm. 2025 Apr 30. [Epub ahead of print]. https://doi.org/10.1177/00185787251337613
  • Achey TS, Hager DR, Little JD. Practice model versus practice advancement: did “model” have a beyond use date? Am J Health Syst Pharm. 2025. In press.
  • Ambade PN, Hoffman Z, Vest TA, et al. Factors influencing communication issues during hospital discharge for older adults in 11 high-income countries: a secondary analysis of the 2021 International Health Policy Survey. BMJ Open. 2025;15:e089430. https://doi.org/10.1136/bmjopen-2024-089430
  • Cawley M, Carlson R, Vest TA, Eckel SF. Machine-assisted literature screening for a medication use process related systematic review. Am J Health Syst Pharm. 2025;82(10):551-558. https://doi.org/10.1093/ajhp/zxae357
  • Eckel SF, Vest TA, Gazda NP, Peek GK. Defining and describing the medication use process within the ambulatory care setting. Am J Health Syst Pharm. 2025;82(14):851-856. https://doi.org/10.1093/ajhp/zxae403
  • Gazda NP, Peek GK, Vest TA, Francart, S, Eckel SF. Bridging the continuity: practice-enhancing publications about the ambulatory care medication use process in 2023. Am J Health Syst Pharm. 2025;82(15):e681-e695. https://doi.org/10.1093/ajhp/zxaf012
  • Gazda NP, Vest TA, Peek GK, Francart S, Eckel SF. Bridging the continuity: practice-enhancing publications about the ambulatory care medication use process in 2021. Am J Health Syst Pharm. 2025;82(8):461-473. https://doi.org/10.1093/ajhp/zxae358
  • Gazda NP, Vest TA, Peek GK, Francart S, Eckel SF. Bridging the continuity: practice-enhancing publications about the ambulatory care medication use process in 2022. Am J Health Syst Pharm. 2025;82(3):e182-e189. https://doi.org/10.1093/ajhp/zxae338

Other Notable Achievements

  • Tom Achey: Fellow Practitioner Recognition (FASHP), American Society of Health-System Pharmacists.

Community-Based PRN

The Community-Based PRN is looking forward to another great year working with ACCP to uplift the value of clinical community pharmacy and improve patient care across the health care continuum.

 Promotions

  • Joseph Fava: Associate Professor, Wayne State University.

 Publications

  • Eddy E, Dominguez E, Courtney L, Klein M, Hall R. Implementation of a mandatory immunization certification course with co-curricular components within a Pharm.D. curriculum. Curr Pharm Teach Learn. 2025. In press. https://doi.org/10/1016/j.cptl.2025.102459
  • Herbert SMC, Castelli G, Casagrande AJ, Brownlee K, Klatt P, Suyama J, et al. Interprofessional care and education at the Pitt Vaccination and Health Connection Hub: a description of collaboration in a community pharmacy across six health science schools. J Am Coll Clin Pharm. 2025 Apr 21. [Epub ahead of print]. https://doi.org/10.1002/jac5.70070
  • Ross LA, Dumont Z, Herbert SMC, Irwin AN, McDonough R, Anderson L, et al. Framework and recommendations to support bidirectional information sharing between community pharmacies and other health care settings. J Am Coll Clin Pharm. 2025;8:406-412. https://doi.org/10.1002/jac5.70027
  • Havens G, Lahrman R, Kissel J, Vaughn T, Li J, Hall LE. Prioritizing patient value regarding pharmacy culture in a LGBTQ+-focused pharmacy. J Am Pharm Assoc (2003). 2025;65(5):102448. https://doi.org/10.1016/j.japh.2025.102448

Presentations

  • Joseph Fava: Immunization update 2025. Presented at: Michigan Pharmacists Association Annual Convention & Exposition; April 12, 2025; Traverse City, MI.

Other Notable Achievements

  • Jordan Ballou: Appointed Associate Dean for Student Affairs, University of South Carolina.

Critical Care PRN

Promotions

  • Austin Camp: Tenure, Union University College of Pharmacy.
  • Mojdeh Heavner: Professor of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy.
  • Payal Patel: Critical Care Pharmacy Coordinator, Assistant Residency Program Director, Memorial Hospital West PGY1 Residency Program.
  • Jodi Taylor: Assistant Dean for Curricular Affairs, University of Florida College of Pharmacy.
  • Toby Trujillo: Vice Chair of Clinical Programs, Department of Pharmacy, University of Colorado Skaggs School of Pharmacy.

 Awards

  • Whitney Anderson: Scholarship Award, Neuroscience Section, Society of Critical Care Medicine.
  • Leslie Hamilton: P3 Pinner and Faculty Commencement Hooder, College of Pharmacy, University of Tennessee Health Science Center.
  • Anthony Hawkins:
    • Creative Teaching Award, University of Georgia.
    • Publication of the Year Award, Georgia Society of Health-System Pharmacists.
  • Rachel Klosko: Dean’s Award for Faculty Service, Binghamton University School of Pharmacy and Pharmaceutical Sciences.
  • Desiree Kosmisky: Society of Critical Care Medicine (SCCM) Best of SCCM Congress.
  • Kaitlin Landoff: Presidential Citation Award, Society of Critical Care Medicine.
  • Megan Rech: Top Viewed Article, Journal of the American College of Clinical Pharmacy.
  • Melissa Santibañez: Golden Apple Award, College of Pharmacy, Nova Southeastern University.
  • Susan Smith: Outstanding Community Volunteer Service Award, Georgia Society of Health-System Pharmacists.
  • Erik Wasowski: BPS Award, Ohio College of Clinical Pharmacy.

 Publications

  • Bainum TB, Krueger C, Hawkins WA. Cultivating expert thinking skills for experiential pharmacy trainees. Am J Health Syst Pharm. 2025;82(9):e472-e478. https://doi.org/10.1093/ajhp/zxae366
  • Bastin MLT, Rech MA, Betthauser KD, Heavner MS, Horng M, Lemieux SM, Lumpkin M, McCreary EK, Ruggero MA, et al. Impact of beta-lactam antibiotic renal dose adjustment on clinical outcomes in patients with septic shock and acute kidney injury from gram-negative bloodstream infections: a multicenter observational study. CMI Commun. 2025;2(3):105084. https://doi.org/10.1016/j.cmicom.2025.105084
  • Blotske K, Patel T, Trujillo T, Marlar M, Lind S, Kramer H, Hassell K, Kiser T. Evaluation of rivaroxaban exposure via anti-Xa levels during VTE prophylaxis in hospitalized patients. Clin Appl Thromb Hemost. 2025;31:10760296251319961. https://doi.org/10.1177/10760296251319961
  • Healy WJ, Bhatt AN, Sengupta S, Abolhassani A, Brower D, Forehand C, Keats K, et al. Awakening sleep medicine: the transformative role of artificial intelligence in sleep health. Curr Sleep Med Rep. 2025;11:13. https://doi.org/10.1007/s40675-025-00328-w
  • East LF, Hamilton LA, Christianson T, et al. Multimodal pain control in headaches associated with subarachnoid hemorrhage. Clin Neuropharmacol. 2025;48(3):89-92. https://doi.org/10.1097/WNF.0000000000000631
  • Wallhauser HM, Hamilton LA, Brown SR, et al. Association between insulin dose and hyperglycemia in hospitalized adults with ischemic stroke on continuous enteral nutrition: a retrospective cohort study. JPEN J Parenter Enteral Nutr. 2025;49(6):752-757. https://doi.org/10.1002/jpen.2787
  • Yang H, Hu M, Most A, Hawkins WA, Murray B, Smith SE, Li S, Sikora A. Evaluating accuracy and reproducibility of large language model performance on critical care assessments in pharmacy education. Front Artif Intell. 2025;7:1514896. https://doi.org/10.3389/frai.2024.1514896
  • Heavner MS, Rose C, Dormer M, Morgan JA, Haines ST. Characterization of faculty practice evaluation processes within US schools of pharmacy. J Am Coll Clin Pharm. 2025. [Epub ahead of print]. https://doi.org/10.1002/jac5.70062
  • Jacobi J. Foreword. In: Alzaidi Y, Gebily MA, eds. The Pharmacist’s Expanded Role in Critical Care Medicine: A Comprehensive Guide for Practitioners and Trainees. Springer Nature Switzerland; 2025.
  • Hidalgo JL, Kumar VK, Akech SO, Myatra SN, Jacob ST, Kortz T, Vasquez AA, Bazzano MCJ, Diaz M, Rodriguez JDR, Garcia ALN, Giron R, Jacobi J, et al. The sepsis chain of survival: a comprehensive framework for improving sepsis outcomes. Crit Care Med. 2025 Jul 16. [Epub ahead of print]. https://doi.org/10.1097/CCM.0000000000006796
  • Pham HT, Castelino RL, Kiser TH, Trujillo TC, et al. Ethical interventions: revisiting the assessment tools for health-system pharmacists. Front Med (Lausanne). 2025;12:1536044. https://doi.org/10.3389/fmed.2025.1536044
  • Klosko RC, Whitson B, Lampert B, McLaughlin E, Orzel L. Safety of enoxaparin in patients implanted with continuous flow left ventricular assist devices. Artif Organs. 2025;49(4):639-648. https://doi.org/10.1111/aor.14908
  • Linn DD, Rech MA, Faine BA. Strategies to prevent awareness with paralysis following administration of neuromuscular blocking agents. Am J Health Syst Pharm. 2025;82(17):e736-e742. https://doi.org/10.1093/ajhp/zxaf072
  • Renew JR, Linn DD. Pro: The use of sugammadex does not preclude the need for objective neuromuscular monitoring. J Cardiothorac Vasc Anesth. 2025;39(7):1878-1881. https://doi.org/10.1053/j.jvca.2025.04.001
  • Lucas RC, Govel JC, Nasta GN, Brooks M, Clark T, Johnston YA, et al. Utilizing panel discussions to facilitate interprofessional learning: lessons from the rural and underserved service track. J Am Coll Clin Pharm. 2025 Jun 27. [Epub ahead of print]. https://doi.org/10.1002/jac5.70074
  • Chan A, Baker W, Abazia D, Bauman J, DeVane L, Goodlet K, Hall N, Hicks J, Jones E, Chi-Lua L, Moore D, Nelson N, Putney K, Sosa A, Trujillo T, et al. ACCP commentary: Impact of artificial intelligence on future clinical pharmacy research and scholarship. J Am Coll Clin Pharm. 2025;8(4):311-316. https://doi.org/10.1002/jac5.70003
  • Rech MA, Budde E, Evans CT, Finch D, Xia Y, Huo Z, Han JH. Andexanet alfa increases 30-day thrombotic events relative to four-factor prothrombin complex concentrate for factor Xa inhibitors-related intracerebral hemorrhage in veterans. Am J Emerg Med. 2025;97:97-102. https://doi.org/10.1016/j.ajem.2025.07.037
  • Zhou CJ, Deng A, Hodkiewicz V, Rech MA, Sterk EJ. Improving initial management of septic patients: comparing intravenous push vs. intravenous piggyback antibiotics. J Emerg Med. 2025;75:188-196. https://doi.org/10.1016/j.jemermed.2025.03.010
  • Zimmerman DE, Rech MA, Covvey JR, Acquisto NM, Slocum GW, Howington GT, Woolum JA, Flack T, Ray L, Porter B, et al. Hepatitis B vaccination and immune globulin administration in patients presenting to the emergency department following sexual assault. Am J Emerg Med. 2025;97:188-192. https://doi.org/10.1016/j.ajem.2025.07.060
  • Santibañez M. Critical care. In: Beckett RD, Bente JA, Bondi DS, et al, eds. Updates in Therapeutics®: Pharmacotherapy Preparatory Review and Recertification Course. American College of Clinical Pharmacy; 2025 (volume 2):295-356.
  • Santibañez M. Upper respiratory tract infections. In: Sutton SS, ed. McGraw-Hill’s NAPLEX Review Guide. 5th ed. McGraw-Hill; 2025.
  • Santibañez M, Rincon-Ponte AM, Sastre Perez G. Antimicrobial stewardship principles for critically ill patients. AACN Adv Crit Care. 2025;36(1):5-13. https://doi.org/10.4037/aacnacc2025715
  • Singh-Franco D, Santibañez M, Pham H, Metzner M, Hernandez-Toledo L. Resmetirom for moderate to advanced liver fibrosis. J Nurs Pract. 2025;21(5):105330. https://doi.org/10.1016/j.nurpra.2025.105330
  • Datt M, Sikora A, Henry K. Association between experienced mentorship and successful publication of PGY1 resident research at an academic medical center. Hosp Pharm. 2025 Mar 12:00185787251326237. https://doi.org/10.1177/00185787251326237
  • Smith B, Henry K, Nguyen K, Sikora A. A letter addressing the impact of a flex ICU position on workload. Hosp Pharm. 2025;60(4):316-318. https://doi.org/10.1177/00185787251318287
  • Smith SE, Smith LT, Sikora A, Branan TN, Bland CM, Hawkins WA. Relationship between medication regimen complexity and pharmacist engagement in fluid stewardship. Am J Health Syst Pharm. 2025;82(11):e529-e535. https://doi.org/10.1093/ajhp/zxae369
  • Pham C, Williams N, Zavala S. Methemoglobinemia in the setting of hemolysis: a case report suggesting reflex lab for patients with oxygen saturation gap for early detection and diagnosis. J Pharm Pract. 2025 Feb 16. [Epub ahead of print]. https://doi.org/10.1177/08971900251321701
  • Zhang MM, Leshko NA, Elliott GC. Safety of intravenous push administration of high-dose (≥3 g) levetiracetam. Ann Pharmacother. 2025 Jun 16. [Epub ahead of print]. https://doi.org/10.1177/10600280251345079

 Other Notable Achievements

  • Whitney Anderson:
    • Chair-Elect, Ohio Chapter Society of Critical Care Medicine.
    • Chair, Communications Committee (2024-2026), Ohio Chapter Society of Critical Care Medicine.
  • Sarah Cogle: Fellow of the American College of Critical Care Medicine (FCCM).
  • Kathryn Connor: Fellow of the American College of Critical Care Medicine (FCCM).
  • Jenna Cox: Fellow of the American College of Critical Care Medicine (FCCM).
  • Laura Ebbitt: Fellow of the American College of Critical Care Medicine (FCCM).
  • Gabrielle Gibson: Fellow of the American College of Critical Care Medicine (FCCM).
  • Leslie Hamilton: ACCP Credentials FCCP Committee Chair.
  • Joanna He:
    • SCCM CPP Patient Safety Committee Patient Safety Updates Senior Charge Lead.
    • SCCM Southeast Chapter Social Media Committee Co-Chair.
  • Kelli Henry:
    • SCCM CPP Patient Safety Committee-Programming Junior Charge Lead.
    • SCCM CPP Practice Advancement Committee-Research and Scholarship Ideas Charge Lead.
  • Rachel Klosko:
    • Past President – Southern Tier Society of Health-System Pharmacists.
    • Past President – NYS ACCP.
  • Desiree Kosmisky: Secretary, Carolinas/Virginias Chapter of SCCM.
  • Kaitlin Landolf: SCCM Baltimore Chapter President.
  • Jessica Ledford: Fellow of the American College of Critical Care Medicine (FCCM).
  • Angel Maldonado: Fellow of the American College of Critical Care Medicine (FCCM).
  • Megan Rech:
    • Society for Academic Emergency Medicine (SAEM), Academy of Emergency Medicine Pharmacists (AEMP), Inaugural President.
    • Society of Critical Care Medicine (SCCM) Clinical Pharmacy and Pharmacology (CPP) Section, Immediate Past Chair.
  • Michael Rudoni: Fellow of the American College of Critical Care Medicine (FCCM).
  • Zachary Smith: Fellow of the American College of Critical Care Medicine (FCCM).
  • Toby Trujillo: President-Elect of ACCP.

Drug Information PRN

Promotions

  • Haley N. Johnson: Associate Professor, Pharmacy Practice; St. Louis College of Pharmacy at University of Health Sciences and Pharmacy, St. Louis, MO.
  • Audrey Kostrzewa: Professor of Pharmacy Practice, Concordia University Wisconsin, Mequon, WI.

Grants

  • Brittany Bissel Turpin: ACCP Emergency Medicine PRN Member Research Grant. Co-Investigator.

Publications

  • Bauer SR, Wieruszewski PM, Bissell Turpin BD, Dugar S, Sacha GL, Sato R, et al. Adjunctive vasopressors and short-term mortality in adults with septic shock: a systematic review and meta-analysis. Shock. 2025;63(5):668-676. https://doi.org/10.1097/SHK.0000000000002558
  • Gilbert BW, Bissell Turpin BD. Complexities of evidence-based medicine: challenges for practice and policy development. Am J Health Syst Pharm. 2025;82(6):359-363. https://doi.org/10.1093/ajhp/zxae253
  • Jones BE, Ramirez JA, Oren E, Soni NJ, Sullivan LR, Restrepo MI, Musher DM, Erstad BL, Pickens C, Vaughn VM, Helgeson SA, Crothers K, Metlay JP, Bissell Turpin BD, et al. Diagnosis and management of community-acquired pneumonia. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2025 Jul 18. [Epub ahead of print]. https://doi.org/10.1164/rccm.202507-1692ST
  • Lee KC, Haines S, Gable KN, Bruce SP, Kostrzewa A, Mantione MM, et al. Exploration of psychosocial hazards: job demands, rewards and recognitions, and autonomy to address workforce well-being. Am J Pharm Educ. 2025;89(8):101459. https://doi.org/10.1016/j.ajpe.2025.101459
  • Saad M, Maisch NM. Levothyroxine absorption in patients with celiac disease: challenges and therapeutic strategies. Ann Pharmacother. 2025 Jul 29. [Epub ahead of print]. https://doi.org/10.1177/10600280251361914
  • Sibbesen J, Rich J. Understanding the FDA approval process and PDUFA dates. Pharmacy Times. 2025;14(2). https://www.pharmacytimes.com/view/understanding-the-fda-approval-process-and-pdufa-dates

Presentations

  • Audrey Kostrzewa: Pharmacists in the know: leveraging drug information resources for practice and teaching. Presented at: AACP Annual Meeting; July 2025; Chicago, IL.

New ACCP Fellows

  • Brittany Bissell Turpin

 Other Notable Achievements

  • Julie Sibbesen: Pharmacogenomics Certificate Program: Test2Learn.

Education and Training PRN

Promotions

  • Tom Achey: Associate Professor, Fred Wilson School of Pharmacy at High Point University.
  • Elizabeth Bald: Associate Professor, University of Utah College of Pharmacy.
  • Haley N. Johnson: Associate Professor, Pharmacy Practice, St. Louis College of Pharmacy at University of Health Sciences and Pharmacy.
  • Jay L. Martello: Clinical Professor, West Virginia University School of Pharmacy.
  • Amanda M. Morrill: Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences.
  • Sarah Vordenberg: Clinical Professor and Associate Chair of the Department of Clinical Pharmacy, University of Michigan College of Pharmacy.

Awards

  • Tom Achey:
    • Fellow Practitioner Recognition, American Society of Health-System Pharmacists.
    • PAI Best Practice Award Finalist, South Carolina Society of Health-System Pharmacists.
  • Nicole Albanese: Western New York Best Practices in Residency Training Award, Western New York Residency Consortium.
  • Paul Boylan:
    • Teacher of the Year, The University of Oklahoma College of Pharmacy.
    • Outstanding Preceptor, The University of Oklahoma College of Pharmacy.
  • Lisa Chastain: Dallas Faculty Preceptor of the Year, Texas Tech University Health Science Center School of Pharmacy.
  • Cait Gibson: VCU Bertha Rolfe Teacher of the Year Award.
  • Anthony Hawkins: Creative Teaching Award, University of Georgia.
  • Kristin Janzen: P2 Teaching Excellence Award, The University of Texas at Austin College of Pharmacy.
  • Erika Kleppinger: Continuing Education Presenter of the Year, Auburn University Harrison College of Pharmacy.
  • Taylor Steuber: 2024 AACP Curriculum SIG Publication Award.
  • Andrew Stone: Preceptor of the Year, OSU Pharmacy Residency Programs.
  • Cole Wilder: Phi Delta Chi Outstanding Chapter Advisor Award.

Grants

  • Cait Gibson. Characterization of First Generation Pharmacy Student Experiences: A Multi-School Qualitative Study. First-Generation and AAPI Student Success Grant, You First at VCU First-Generation Student Success and Research Center. Primary Investigator ($6946.45).
  • Sharmon P. Osae. 2025 Georgia Healthy Family Alliance Community Health Grant Award. Georgia Healthy Family Alliance. Co-Principal Investigator ($5000).

 Publications

  • Achey TS. Off the clock, on purpose: sabbatical or sabotage? Am J Health Syst Pharm. In press.
  • Achey TS, Elliott SN, Harding BW, Lingenfelter EH, Ramp AM. The informed interview: a resource for pharmacy leaders. Hosp Pharm. In press.
  • Achey TS, Griffin HR. Implementation of a self-service data exploration tool within an academic medical center department of pharmacy. Hosp Pharm. 2025 Apr 30. [Epub ahead of print]. https://doi.org/10.1177/00185787251337613
  • Achey TS, Hager DR, Little JD. Practice model versus practice advancement: did “model” have a beyond use date? Letter to the Editor. Am J Health Syst Pharm. In press.
  • Denny O, Albanese NP, Meaney CJ, Siwarski NE, Monte SV. Effectiveness and safety of sodium-glucose cotransporter-2 inhibitor continuation in patients with type 2 diabetes and late-stage chronic kidney disease. J Pharm Technol. 2025;41(2):65-71. https://doi.org/10.1177/87551225241302731
  • Pizzutelli N, Maerten-Rivera J, Albanese N, Desai K, Rosenberg J, Stumm C, et al. Assessment of student well-being and identification of associated factors. Curr Pharm Teach Learn. 2025;17:102298. https://doi.org/10.1016/j.cptl.2025.102298
  • Boylan PM. Case series: Upper respiratory tract infections. In: Irons B, Meredith AH, eds. Ambulatory Care Self-Assessment Program, 2025. ACSAP 2025. American College of Clinical Pharmacy; 2025:29-58.
  • Boylan PM, Dennis V, Neely S, Skrepnek G. Experience using a state board of pharmacy adequate staffing form: a descriptive report. Curr Pharm Teach Learn. 2025;17(6):102326. https://doi.org/10.1016/j.cptl.2025.102326
  • Mishima Y, Townsend G, Clifton S, Butt A, Vandyck K, Boylan P, et al. Andexanet-induced heparin resistance in cardiac surgery: a rapid review of case reports and series. J Thromb Haemost. 2025;23(5):1522-1530. https://doi.org/10.1016/j.jtha.2025.01.008
  • Coffee AN, Smith Marsh D, Elmes-Patel AT. Additional comment on “Pharmacist-managed diabetes care and change in A1C: a retrospective matched cohort study.” J Am Coll Clin Pharm. 2025;8(4):320-320. https://doi.org/10.1002/jac5.70029
  • Chastain DB, Cluck DB, Covert KL. Bacteremia and infective endocarditis. In: Haines ST, Nolin TD, Ellingrod VL, Posey L, Cocohoba J, Holle L, eds. Pharmacotherapy: A Pathophysiologic Approach. 13th ed. McGraw-Hill; 2025.
  • Lanier C, Brumit C, Tharp J, Crawford J, White K, Wilson V, Covert K. Incidence and potential predictors of SGLT2 inhibitor initiation in acutely hospitalized patients with heart failure. Am J Health Syst Pharm. 2025;82(13):e624-e631. https://doi.org/10.1093/ajhp/zxaf025
  • Perry K, Jones S, Stumpff JC, Kruer R, Czosnowski L, Kashiwagi D, et al. Decision fatigue in hospital settings: a scoping review. J Hosp Med. 2025;20(4):385-395. https://doi.org/10.1002/jhm.13550
  • Hanson T, Paloucek F, Elmes-Patel AT. Comment: Safety of phenobarbital versus benzodiazepines for alcohol withdrawal in critically ill patients with primary neurologic injuries. Ann Pharmacother. 2025 Jul 5. [Epub ahead of print]. https://doi.org/10.1177/10600280251351934
  • Harrigfeld S, Elmes-Patel AT. Comment on “Real-world observations of using compounded GLP-1 GIP agonists within a clinical pharmacist-managed cardiometabolic clinic.” J Am Coll Clin Pharm. 2025;8(6):515-516. https://doi.org/10.1002/jac5.70047
  • Stranges PM, Adams KK, Alharir A, Burnam LG, Elmes-Patel AT, Greenlee SB, Infante AF, et al. Pharmacists’ contributions to the management of opioid use disorder. J Am Coll Clin Pharm. 2025;8(6):500-510. https://doi.org/10.1002/jac5.70049
  • Gibson CM, Desai UR, Wesling ME. Factor XI/XIa inhibitors: a potential solution to anticoagulation dilemmas. Expert Opin Pharmacother. 2025;26(5):605-616. https://doi.org/10.1080/14656566.2025.2475192
  • Gibson CM, Escaño AK, McKenzie JJ, Dayanjan SW, Donohoe KL. Enhancing student knowledge and confidence through two sequential total parenteral nutrition active learning approaches. Curr Pharm Teach Learn. 2025;17(9):102396. https://doi.org/10.1016/j.cptl.2025.102396
  • Haines SL, Lee KC, Gable KN, Thigpen J, Gibson CM, Morley S, Crowl AN, et al. Exploration of psychosocial hazards: core values, justice and fairness, and social support to address workforce well-being. Am J Pharm Educ. 2025;89(8):101460. https://doi.org/10.1016/j.ajpe.2025.101460
  • Mnatzaganian CL, Gibson CM, Kipper L, Williams CR, Cat TB. The preceptors’ toolkit for working with struggling pharmacy students. Pharmacy. 2025;13:66. https://doi.org/10.3390/pharmacy13030066
  • Young J, Spisany T, Guidry C, Hong J, Le J, El Rassi E, Boylan P. Dupilumab for chronic obstructive pulmonary disease: a systematic review. Biologics (Basel). 2025;5(1):5. https://doi.org/10.3390/biologics5010005
  • Bainum TB, Krueger C, Hawkins WA. Cultivating expert thinking skills for experiential pharmacy trainees. Am J Health Syst Pharm. 2025;82(9):e472-e478. https://doi.org/10.1093/ajhp/zxae366
  • Smith SE, Smith LT, Sikora A, Branan TN, Bland CM, Hawkins WA. Relationship between medication regimen complexity and pharmacist engagement in fluid stewardship. Am J Health Syst Pharm. 2025;82(11):e529-e535. https://doi.org/10.1093/ajhp/zxae369
  • Addison J, Glowacki B, Kelley D, Janzen KM, Wulfe S. Evaluation of an inpatient automatic dose reduction protocol for concentrated insulin glargine upon therapeutic interchange to insulin detemir on hypoglycemia rates. Am J Health Syst Pharm. 2025;82(14):822-830. https://doi.org/10.1093/ajhp/zxae346
  • Jarrett JB, Elmes-Patel AT, Allen S, Djuric Kachlic M, Schriever A, Driscoll T, et al. Longitudinal preceptor assessment in pharmacy experiential education using entrustable professional activities. Pharmacy (Basel). 2025;13(3):72. https://doi.org/10.3390/pharmacy13030072
  • Kleppinger EL. Transforming a pharmacy self-care course with specifications grading. TD. 2025;18(1):282-295. https://doi.org/10.26209/td2025vol18iss11859
  • Garza KB, Perry S, Jones MC, Camus M, Grobman M, Kleppinger E. Can we do better together? Leveraging simulation-based learning in health professions education. TD. 2025;18(1):267-281. https://doi.org/10.26209/td2025vol18iss11850
  • North K, Dahl B, Dowling-McClay K, Highsmith M. Denosumab-bbdz: a review of the interchangeable biosimilar for the treatment of osteoporosis. Ann Pharmacother. 2025 Jun 12. [Epub ahead of print]. https://doi.org/10.1177/10600280251342581
  • Steuber TD, Trujillo D, Kleppinger EL, Andrus MR, Pinner NA, Hornsby L, et al. Impact of curricular content reduction on student reported mental and physical health. Am J Pharm Educ. 2025;89(3):101367. https://doi.org/10.1016/j.ajpe.2025.101367
  • Salvatore D, Moore J, Steuber TD. Long-acting lipoglycopeptides compared to standard-of-care for the treatment of complicated gram-positive infections: a systematic review and meta-analysis. Int J Antimicrob Agents. 2025;66(5):107581. https://doi.org/10.1016/j.ijantimicag.2025.107581
  • Thayer B, Steuber TD, Rydz A, Fleming J, Sorenson J, Arnold M, et al. Navigating therapeutic drug monitoring of isavuconazole in invasive mold infection on extracorporeal membrane oxygenation: a case report. Innov Pharm. 2025;16(2):6563. https://doi.org/10.24926/iip.v16i2.6563
  • Rhoney DH, Chen AMH, Chung E, Churchwell M, Daugherty K, Kleppinger E, Nelson N, Parker D, Sibicky S, Stowe C, Thornby K, et al. Behavioral foundations for CBPE: using the BCW to advance individual readiness to change. Am J Pharm Educ. 2025;89(9):101470. https://doi.org/10.1016/j.ajpe.2025.101470
  • Wilder JC, Diec S. Exploring benefits of instructional coaching as a model to improve teaching practices in pharmacy education. Am J Pharm Educ. 2025;89(4):101382. https://doi.org/10.1016/j.ajpe.2025.101382
  • Wollen J, Shamsi A, Wilder JC, Bradshaw DA, Davis SR. First professional year student pharmacists’ approaches to resolving drug diversion incidents in a community pharmacy simulation. Curr Pharm Teach Learn. 2025;17(5):102318. https://doi.org/10.1016/j.cptl.2025.102318
  • Williams E. Gout and hyperuricemia. In: Koehler JM, Borchert JS, Slain D, Park SK, Weber ZA, eds. Schwinghammer’s Pharmacotherapy Casebook: A Patient-Focused Approach. 13th ed. McGraw-Hill; 2026. In press.
  • Williams E. Leading with authority: a reservist’s perspective on policy, advocacy, and impact. COA/COF Frontline Newsletter. Jun/Jul 2025;63(5).
  • Williams E, Cox T. ACPE accreditation standards and consideration. In: Pharmacy Foundations: A Non-Pharmacist’s Guide to Pharmacy Education. AACP; 2025. In press.
  • Okolo C, Williams E, Cone C. Other medications. In: King MS, Lipsky MS, eds. Blueprints Family Medicine. 5th ed. Wolters Kluwer Health, 2025:461-466.
  • See S, Nemecek BD, Allen SM, Agada I, Bhat S, Dy Boarman E, Fravel M, Hamblin S, Hynicka L, Kelly K, Kufel WD, May D, McBane SE, Nahata MC, Norgard NB, Schanz C, Schmidt K, Shelton C, Taylor J, Williams E, et al. Education and training of today’s clinical pharmacist. J Am Coll Clin Pharm. 2025 Aug 12. [Epub ahead of print]. https://doi.org/10.1002/jac5.70094

Presentations

  • Boylan PM. Cannabinoids for sleep. Presented at: The Cannabis Boomer Podcast, Santa Cruz Robotics; August 2025; virtual.
  • Coffee A, Elmes AT. The new ZYN-sation sweeping the nation: the emerging use of nicotine pouches and what pharmacists should know. Presented at: Illinois Council of Health-System Pharmacists Spring Meeting; March 2025; virtual.
  • Coffee AN, Messmer SE, Murphy AL, Jimenez AD, Mayer SM, Staton MD, Stark KD, Rashid LM, Martinford TG, Elmes-Patel AT. Rolling out recovery: expanding mobile opioid use disorder services in Illinois. Presented at: National Pharmaceutical Association Annual Convention; August 2025; Cincinnati, OH.
  • Coffee AN, Stranges P, Keller E, Infante A, Martinford T, Rashid L, Elmes-Patel AT. Patient factors associated with hospital discharge on buprenorphine versus methadone. Presented at: American Society of Addiction Medicine Annual Meeting; April 2025; Denver, CO.
  • Coffee AN, Elmes-Patel A. A bitter pill to swallow: career regret in pharmacy and how to exit the cycle. Presented at: AACP Annual Meeting; July 2025; Chicago, IL.
  • Salisbury-Afshar E, Ciraldo K, Messmer S, Elmes AT, Murphy A. How low can you go? Low barrier buprenorphine care delivery models. Presented at: American Society of Addiction Medicine Annual Meeting; April 2025; Denver, CO.
  • W. Anthony Hawkins:
    • Hawkins WA. Using theory and frameworks to develop research questions. Presented at: DiPiro Workshop, AACP Annual Meeting; July 2025; Chicago, IL.
    • Hawkins WA. Transforming pharmacy education: innovation to enhance experiential learning. Presented at: King Saud bin Abdulaziz University for Health Sciences Annual Health Professions Conference; February 2025; virtual.
  • Erika L. Kleppinger:
    • Kleppinger EL. Complementary use of EHRGo and MyDispense for community pharmacy dispensing skill development. Poster snapshot presentation at: Monash University MyDispense Symposium; July 2025; Prato, Italy.
    • Kleppinger EL, Sibicky SL, Rhoney DH, Churchwell MD, Nelson NR. Unlocking competency-based pharmacy education (CBPE): an interactive escape room experience. Presented at: AACP Annual Meeting; July 2025; Chicago, IL.
    • Stafford RA, Kleppinger EL, Walter J, Knockel L, Parrish J. AI-powered patient interviews: revolutionizing student skills across five institutions. Presented at: AACP Annual Meeting; July 2025; Chicago, IL.
  • Stone A. Don’t go breaking my heart: a cardio-oncology primer. Presented at: Department of Pharmacy CE presentation; June 2025; Columbus, OH.
  • Krisy Thornby:
    • Thornby K. Preventing the spread of medical misinformation in an era of information overload. Presented at: Florida Society of Health-System Pharmacists; August 2025; Orlando, FL.
    • Thornby K, Munir F. Medical information: the use of artificial intelligence to answer drug information inquiries. Presented at: American College of Clinical Pharmacy CE Webinar; July 2025; virtual.
    • Thornby K, Chen A, Churchwell M, Chung E. Mapping the journey to practice-readiness: building a competency roadmap in pharmacy education. Presented at: AACP Annual Meeting; July 2025; Chicago, IL.
  • Evan Williams:
    • Williams E, Pizzutelli N, Beckers C, Blake E, Jefferson C. Intentional inclusion to promote staff engagement, wellness, and belonging. Presented at: AACP Annual Meeting; July 2025; Chicago, IL.
    • Williams E, Souria M. Curricular quality assurance and standards 2025. Presented at: AACP Pharmacy Practice Section Webinar; June 2025; virtual.
    • Akunyili A, Brewster C, LeClaire A, Thacker M, Williams E. Building a skilled healthcare workforce to serve our evolving community. Presented at: Neighborhood Health Series; May 2025; Summerlin, NV.
    • Williams E. Biostatistics. Fundamentals of Biostatistics and Clinical Trial Design Workshop. Presented at: ACCP On-Demand Workshop; May 28, 2025; virtual.

Other Notable Achievements

  • Kaitlyn North: Accepted into Tennessee Pharmacists Association Emerging Leaders Academy.

Emergency Medicine PRN

Awards

  • Lauren Beauchamp: Butler University Preceptor of the Year 2024-2025.
  • Megan Rech:
    • Top Viewed Article for paper titled “The Clot Thickens: How to Use Viscoelastic Testing in Critical Illness.” Journal of the American College of Clinical Pharmacy.
    • 2025 Presidential Citation Award, Society of Critical Care Medicine.

Grants

  • Brian Gilbert: 2025 ACCP EMED PRN Research Grant. Principal Investigator ($2500).
  • Emily McGee:
    • 2025 ACCP EMED PRN Research Grant. Principal Investigator ($2500).
    • Rural Health Stroke Education Project, an initiative aimed at improving stroke recognition and thrombolytic administration in rural healthcare centers and EMS agencies. Living Well Foundation Grant.
  • Megan Rech:
    • Evaluating Disparities and Pharmacoequity in Resistant Gram-Negative Infections and Antibiotic Treatment. 2025-2029 HSR Merit Award ($800,000) (10% effort).
    • A Multi-center Retrospective Cohort Study of SUGAmmadex for Neuromuscular Blockade Reversal in the Emergency Department: SUGARED Study. 2025 Investigator-Initiated Grant on behalf of EMPHARM-NET, Merck ($119,827.20).
    • EPEC-Vet. 2024-2026 Biosimilars Policy Evaluation Evidence to Policy Evaluation Center for Veterans ($4,163,042). Amount: 30% effort.
  • Tina Tran: 2025 ACCP EMED PRN Research Grant. Principal Investigator ($2500).

Publications

  • Bonetti A, Booth DY, Higgins S, Nutovits A, Jauch T. Sepsis fluid dosing in patients with congestive heart failure or chronic kidney disease. 2024 ASHP Midyear Clinical Meeting Poster Abstracts. Am J Health Syst Pharm. 2025;82(suppl 1):S1409. https://doi.org/10.1093/ajhp/zxae345
  • Jones S, Li I, Gale J, Fox E, Weisberg S, Carreiro S. A mind-blowing ingestion: intentional plastic explosive consumption resulting in seizures. J Med Toxicol. 2025 Jul 10. [Epub ahead of print]. https://doi.org/10.1007/s13181-025-01084-7
  • Mercer KJ, Ofoegbuna I, Razzack H, Feinstein J, Gonzalez M. Presence of emergency medicine pharmacists is associated with shorter time to administration of prothrombin complex concentrate administration regardless of dosing strategy. Am J Emerg Med. 2025;95:147-152. https://doi.org/10.1016/j.ajem.2025.05.032
  • Castillo RM, Madhavaram J, Tran M, Chilappa R, Mercer KJ. Evaluation of patient outcomes associated with lactated Ringers versus normal saline in patients presenting with diabetic ketoacidosis in a multicenter health system. J Emerg Crit Care Med. 2025;9:11. https://doi.org/10.21037/jeccm-24-101
  • Joachim AC, Mercer KJ, Gutierrez MA, Waxler CM, Aradhya SN. Diltiazem vs metoprolol for atrial fibrillation with rapid ventricular response in heart failure with reduced ejection fraction in emergency departments. Front Emerg Med. 2025. In press.
  • Rech MA, Aggarwal NT, Hwang U. New frontier, new challenges—recognizing and managing adverse effects of antiamyloid therapies. JAMA Intern Med. 2025;185(8):1029-1031. https://doi.org/10.1001/jamainternmed.2025.2242
  • Rech MA, Brown C, Slocum GW, Gilbert BW, Aggarwal D, Howington GT, et al. Impact of desmopressin on hematoma expansion in patients presenting to the emergency department on antiplatelet therapy. Am J Emerg Med. 2025;93:126-131. https://doi.org/10.1016/j.ajem.2025.03.052
  • Rech MA, Budde E, Evans CT, Finch D, Xia Y, Huo Z, et al. Andexanet alfa increases 30-day thrombotic events relative to four-factor prothrombin complex concentrate for factor Xa inhibitors-related intracerebral hemorrhage in veterans. Am J Emerg Med. 2025;97:97-102. https://doi.org/10.1016/j.ajem.2025.07.037
  • Rech MA, Gottlieb M. Amiodarone should be the first-line antiarrhythmic treatment for pulseless ventricular tachycardia and ventricular fibrillation. Ann Emerg Med. 2025;85(5):447-448. https://doi.org/10.1016/j.annemergmed.2024.09.020
  • Rech MA, Gottlieb M. Linezolid is the preferred empiric antitoxin antibiotic for group A streptococcal necrotizing soft tissue infections. Ann Emerg Med. 2025;85(4):358-359. https://doi.org/10.1016/j.annemergmed.2024.06.017
  • Dager WE, Rech MA, Gilbert BW. Reversing anticoagulants: influence of anticoagulation stewardship and key considerations for optimizing outcomes. Ann Pharmacother. 2025 Aug 3. [Epub ahead of print]. https://doi.org/10.1177/10600280251356019
  • Feldman R, Faine B, Rech MA, Zimmerman DE, Flack T, Howington GT, Laub J, Porter B, Slocum GW, Zepeski A, Santiago RD, Woolum J, et al. CuratED: the emergency medicine pharmacotherapy literature of 2024. Am J Emerg Med. 2025;93:146-153. https://doi.org/10.1016/j.ajem.2025.03.046
  • Feldman R, Hovis Z, Rech MA. Engaging pharmacists in strategies for navigating prescription drug costs. JAMA. 2025;333(14):1261-1262. https://doi.org/10.1001/jama.2024.27823
  • Linn DD, Rech MA, Faine BA. Strategies to prevent awareness with paralysis following administration of neuromuscular blocking agents. Am J Health Syst Pharm. 2025;82(17):e736-e742. https://doi.org/10.1093/ajhp/zxaf072
  • Thompson Bastin ML, Rech MA, Betthauser KD, Heavner MS, Horng M, Lemieux SM, Lumpkin M, McCreary EK, Ruggero MA, Wieruszewski PM, et al. Impact of beta-lactam antibiotic renal dose adjustment on clinical outcomes in patients with septic shock and acute kidney injury from gram-negative bloodstream infections: a multicenter observational study. CMI Commun. 2025;2(3):105084. https://doi.org/10.1016/j.cmicom.2025.105084
  • Zepeski AE, Nguyen L, Vakkalanka JP, Rech MA, Brown CS, Sarangarm P, et al. Risk factors for enterococcal urinary tract infection in emergency department patients: a sub-analysis of the UNTRIED study. Am J Emerg Med. 2025;96:187-190. https://doi.org/10.1016/j.ajem.2025.06.057
  • Zhou CJ, Deng A, Hodkiewicz V, Rech MA, Sterk EJ. Improving initial management of septic patients: comparing intravenous push vs. intravenous piggyback antibiotics. J Emerg Med. 2025;75:188-196. https://doi.org/10.1016/j.jemermed.2025.03.010
  • Guidos J, Singh R, Smith A, Feldman R. From policy to practice: implementation of emergency medicine pharmacist medication administration. Am J Health Syst Pharm. 2025 Jun 2. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxaf130
  • Burnham K, Akins RL, Tran C, Crotty MP, Lin F, Philip C. Evaluation of emergency medicine pharmacist impact on blood culture review and management following discharge. Am J Emerg Med. 2025;94:201-207. https://doi.org/10.1016/j.ajem.2025.05.002
  • Guerrero Miranda S, Ofoegbuna I, Tran M, Jutba AS, Vo C. Evaluating the safety of tenecteplase versus alteplase for acute ischemic stroke. Emerg Care Med. 2025;2(3):37. https://doi.org/10.3390/ecm2030037
  • Zimmerman DE, Rech MA, Covvey JR, Acquisto NM, Slocum GW, Howington GT, Woolum JA, Flack T, Ray L, Porter B, et al. Hepatitis B vaccination and immune globulin administration in patients presenting to the emergency department following sexual assault. Am J Emerg Med. 2025;97:188-192. https://doi.org/10.1016/j.ajem.2025.07.060

Presentations

  • Deborah Booth:
    • Booth DY, Lark J, Higgins S. Sepsis: swift solutions and saving lives. Presented at: Continuing Education Presentation for Nurses, New Jersey Emergency Nurses Association Annual Meeting; March 2025; Atlantic City, NJ.
    • Booth DY, Meininger M. Don’t go breaking my heart: calcium channel and beta blocker toxicity. Presented at: Continuing Education Presentation for Nurses, New Jersey Emergency Nurses Association Annual Meeting; March 2025; Atlantic City, NJ.

New ACCP Fellows

  • Sarah Hyland

Other Notable Achievements

  • Deborah Booth: Society for Emergency Medicine Pharmacists (SEMP), Research Chair.
  • Olivia Collins: New PGY2 Emergency Medicine Pharmacy Residency Program Director, Baylor University Medical Center, Dallas, TX.
  • Mustafa Jawad: Pharmacy e-learning initiative for students in Iraq, integrating clinical case discussions and pharmacokinetics tutorials, Founder and Leader.
  • Emily McGee:
    • BCEMP.
    • New National Registry of Emergency Medical Technicians.
  • Megan Rech:
    • Inaugural President, Society for Academic Emergency Medicine (SAEM), Academy of Emergency Medicine Pharmacists (AEMP).
    • Immediate Past Chair, Society of Critical Care Medicine (SCCM) Clinical Pharmacy and Pharmacology (CPP) Section.
  • Ravipal Singh: Emergency Medicine Pharmacist for 10+ Years.
  • Tina Tran:
    • Programming Co-Chair-Elect, Society for Academic Emergency Medicine (SAEM), Academy of Emergency Medicine Pharmacists (AEMP).
    • 24/7 Emergency Medicine Pharmacist Shift Coverage Expansion.
  • Christine Vo: BCEMP.

Endocrine and Metabolism PRN

Promotions

  • Ann Philbrick: Professor, University of Minnesota College of Pharmacy.

 Awards

  • Nicole Albanese: Western New York Best Practices in Residency Training Award, Western New York Residency Preceptor Consortium.
  • Daphne Smith Marsh: 2024-2025 Interprofessional Teacher of the Year Award, UIC Family Medicine Residency Program.

Grants

  • Skylar Harrigfeld, Lauren Cunningham, Daphne Smith Marsh, John Shilka, Elizabeth Van Dril: Improving Adherence to Guideline-Directed Medical Therapies in Patients with Type 2 Diabetes and Chronic Kidney Disease. Bayer/Women in Nephrology (WIN)/National Kidney Foundation (NKF) Grant. Co-Investigators ($20,000).

Publications

  • Denny O, Albanese NP, Meaney CJ, Siwarski NE, Monte SV. Effectiveness and safety of sodium-glucose cotransporter-2 inhibitor continuation in patients with type 2 diabetes and late-stage chronic kidney disease. J Pharm Technol. 2025;41(2):65-71. https://doi.org/10.1177/87551225241302731
  • Pizzutelli N, Maerten-Rivera J, Albanese N, Desai K, Rosenberg J, Stumm C, et al. Assessment of student well-being and identification of associated factors. Curr Pharm Teach Learn. 2025;17:102298. https://doi.org/10.1016/j.cptl.2025.102298
  • Clements J, Schumacher C. Pharmacists in diabetes management: enhancing patient care through practice, education, and advocacy. J Am Coll Clin Pharm. 2025;8:74-76. https://doi.org/10.1002/jac5.2077
  • Eagan K, Bolch C, Van Dril E, Schumacher C. Changes in serum potassium in people with type 2 diabetes taking sodium-glucose co-transporter-2 inhibitors. Pharmacotherapy. 2025;45(4):194-202. https://doi.org/10.1002/phar.70006
  • Coffee A, Smith Marsh D, Elmes-Patel A. Additional comment on “Pharmacist‐managed diabetes care and change in A1C: a retrospective matched cohort study.” J Am Coll Clin Pharm. 2025;8(4):320. https://doi.org/10.1002/jac5.70029

Presentations

  • Daphne Smith Marsh:
    • Integration of inclusive language in didactic and experiential instruction. Presented at: 2025 AACP Annual Meeting; July 2025; Chicago, IL.
    • Redefining obesity care: a comprehensive primary care workshop. Presenter and panelist. Presented at: Illinois Academy of Family Physicians; May 2025; virtual.
    • Pharmacist-mobile care clinic partnership to provide community-based health education & screenings in underserved communities. Poster presented at: 2025 American Pharmacists Association Annual Meeting; March 2025; Nashville, TN.

Other Notable Achievements

  • Liz Van Dril: Appointed to the Editorial Board of the American Diabetes Association’s new journal, Diabetes, Obesity, and Cardiometabolic CARE.

Geriatrics PRN

Promotions

  • Allison Hursman: Population Health Pharmacist, Essentia Health.

 Awards

  • Allison Hursman:
    • 2025 Stewardship Value Award, Essentia Health.
    • 2025 Best Practices Award, North Dakota Society of Health-System Pharmacists.

 Publications

  • Hursman A, Wanner H, Rubinstein E. Empowering pharmacy technicians as vaccine champions: a pilot study in independent community pharmacies. J Am Pharm Assoc (2003). 2025;65(1):102257. https://doi.org/10.1016/j.japh.2024.102257
  • Strand MA, Hursman A, Maack B, Petry N, Yang R. A faculty development series on race and ethnicity in pharmacy education. Curr Pharm Teach Learn. 2025;17(1):102210. https://doi.org/10.1016/j.cptl.2024.102210
  • Hutchison LC, Sleeper RB, eds. Fundamentals of Geriatric Pharmacotherapy: An Evidence-Based Approach. 3rd ed. American Society of Health-System Pharmacists; 2025.
  • Nguyen J, Arnaout S, Levison B, Lo N, Price ET, Peron EP, Crouse EL, Sargent L, Zimmerman KM, Slattum PW, Donohoe KL. Secondary stroke prevention trends in low-income community-dwelling older individuals. Sr Care Pharm. 2025;40(5):223-229. https://doi.org/10.4140/TCP.n.2025.223

 Other Notable Achievements

  • Sum Lam:
    • President-Elect, Long Island Society of Health-System Pharmacists (LISHP), a chapter of New York State Council of Health-System Pharmacists (NYSCHP).
    • ACCP Member Spotlight. ACCP Report. July 2025.

GI/Liver/Nutrition PRN

Awards

  • Sarah Cogle: Auburn University Alumni Association 20 Under 40, 2025 Class.

 Publications

  • Dickerson RN, Afolabi TM, Bingham AL, Canada TW, Chan LN, Cogle SV, et al. Significant published articles in 2024 for pharmacy nutrition support practice. Hosp Pharm. 2025 May 20. [Epub ahead of print]. https://doi.org/10.1177/00185787251337596
  • Singh-Franco D, Santibañez M, Pham H, Metzner M, Hernandez-Toledo L. Resmetirom for moderate to advanced liver fibrosis. J Nurse Pract. 2025;21(5):105330. https://doi.org/10.1016/j.nurpra.2025.105330
  • Santibañez M, Lounsbury N, Morena M, Singh-Franco D. Thrombosis secondary to intravenous dicyclomine administration: a case report and literature review. J Pharm Pract. 2025 Mar 14. [Epub ahead of print]. https://doi.org/10.1177/08971900251326808

 Presentations

  • Sarah Cogle:
    • Cogle SV. Call a code: it’s time to update parenteral nutrition compatibility and stability practices. In: Beyond the Bag—A Clinician’s Guide to Parenteral Nutrition Compatibility and Stability. Presented at: ASPEN Nutrition Science and Practice Conference; March 23, 2025; Columbus, OH.
    • Cogle SV. Mixing it up: parenteral nutrition formulations, compatibility, and compounding. In: Basic Skills in Parenteral Nutrition Management Skills Lab. Presented at: ASPEN Nutrition Science and Practice Conference; March 23, 2025; Columbus, OH.
    • Cogle SV, Mulherin DM, Wishmeyer P, DePriest A. It just hits different: incorporating social media into nutrition support education and advocacy. Presented at: ASPEN Nutrition Science and Practice Conference; March 25, 2025; Columbus, OH.
  • Beltran G, Singh-Franco D. Benefits and current limitations of AI for medication safety. Educational poster presentation at: The 121st National Association of Boards of Pharmacy (NABP) Annual Meeting; May 16, 2025; Fort Lauderdale, FL.

 Other Notable Achievements

  • Sarah Cogle: Fellow, American Society for Parenteral and Enteral Nutrition.

Global Health PRN

Promotions

  • Caitlin Gibson: Director of International Programs, Virginia Commonwealth University.
  • Kathy Monangai: Senior Program Manager, Bristol Myers Squibb.
  • Allie Taylor: Senior Director of Global Health Education at University of Pittsburgh Medical Center St. Margaret.

Awards

  • Caitlin Gibson: AACP Emerging Teaching Scholar Award, VCU SOP Bertha Rolfe Teacher of the Year Award.
  • Emily Peron: VCU Center for Interprofessional Education and Collaborative Care Faculty Recognition Award.
  • Hanna Rotundo: Dean’s Award for Excellence in Teaching at University of Louisiana Monroe.
  • Allie Taylor: Above and Beyond Award at University of Pittsburgh Medical Center.

Publications

  • Gibson CM, Desai UR, Wesling ME. Factor XI/XIa inhibitors: a potential solution to anticoagulation dilemmas. Expert Opin Pharmacother. 2025;26(5):605-616. https://doi.org/10.1080/14656566.2025.2475192
  • Gibson CM, Escaño AK, McKenzie JJ, Dayanjan SW, Donohoe KL. Enhancing student knowledge and confidence through two sequential total parenteral nutrition active learning approaches. Curr Pharm Teach Learn. 2025;17(9):102396. https://doi.org/10.1016/j.cptl.2025.102396
  • Gibson CM, Howard ML, Haight RC. Validation of an instrument to assess student pharmacist self-authorship. Curr Pharm Teach Learn. 2025;17(2):102264. https://doi.org/10.1016/j.cptl.2024.102264
  • Clements JN, McClendon K, Borchert J, Ciapala SRL, Courtney LA, Cummings J, Fallon JM, Fritz MK, Gibson CM, et al. ACCP guideline: teaching experiences in pharmacy residency. J Am Coll Clin Pharm. 2025;8:62-69. https://doi.org/10.1002/jac5.2066
  • Haines SL, Lee KC, Gable KN, Thigpen J, Gibson CM, Morley S, et al. Exploration of psychosocial hazards: core values, justice and fairness, and social support to address workforce well-being. Am J Pharm Educ. 2025;89(8):101460. https://doi.org/10.1016/j.ajpe.2025.101460
  • Mnatzaganian CL, Gibson CM, Kipper L, Williams CR, Cat TB. The preceptors’ toolkit for working with struggling pharmacy students. Pharmacy. 2025;13(3):66. https://doi.org/10.3390/pharmacy13030066
  • Santevecchi B, Manigaba K, Childs-Kean L. Bone voyage: navigating updates in the management of bone and joint infections. Curr Infect Dis Rep. 2025;27(5). https://doi.org/10.1007/s11908-024-00855-7
  • O’Neill ET, Huang AW, Wilson-Barthes M, Manji I, Kigen G, Busakhala N, Nyanje S, Galárraga O, Pastakia SD. A cost-effectiveness analysis of rivaroxaban compared to warfarin for the management of venous thromboembolism in western Kenya. Clin Drug Investig. 2025;45(8):565-574. https://doi.org/10.1007/s40261-025-01454-7
  • Peron EP, McDaniel J, Van Tassell B, Donohoe KL. An active-learning laboratory on urinary incontinence products for pharmacy students. Curr Pharm Teach Learn. 2024;16(10):102135. https://doi.org/10.1016/j.cptl.2024.102135
  • Donohoe KL, Van Tassell B, Gregory A, Burns D, Mader K, Lee S, Bitor R, Peron EP. An interprofessional active-learning laboratory on urinary incontinence for pharmacy, nursing, and occupational therapy students. J Interprof Educ Pract. 2024;35:100697. https://doi.org/10.1016/j.xjep.2024.100697
  • Nguyen J, Arnaout S, Levison B, Lo N, Price ET, Peron EP, et al. Secondary stroke prevention trends in low-income community-dwelling older individuals. Sr Care Pharm. 2025;40(5):223-229. https://doi.org/10.4140/TCP.n.2025.223
  • Castelli G, Winters S, Taylor A, Ge Y. Using social media to teach about and engage residents in evidence-based medicine. Fam Med. 2024;56(9):572-578. https://doi.org/10.22454/FamMed.2024.808735
  • Molnar C, Stiteler C, Stachler E, Taylor A. In patients with hyperkalemia, does discontinuing a RAAS inhibitor have a clinical benefit? Evid Based Pract. 2025;28(8):26-27. https://doi.org/10.1097/EBP.0000000000002426
  • Stachler E, Reigh A, Taylor A, Haugh A. Do patients with moderate-to-severe dementia experience less cognitive decline on memantine monotherapy than patients on both memantine and donepezil? Evid Based Pract. 2024;28(4):14-15. https://doi.org/10.1097/EBP.0000000000002280

Other Notable Achievements

  • Genet Azang-Njaah: Started a foundation, Medical Missions Foundation, that promotes education and training in Cameroon.
  • Kara Birrer: Two disaster deployments through Samaritan’s Purse.
  • David Hachey: 5-month sabbatical at the University of Namibia.
  • Arzu Moosvi: Master’s degree in Global Medicine, University of Southern California.
  • Martha Ndung’u: ACCP MeRIT Scholar 2025-2027.
  • Kim Novak: Elected President-Elect of the Pediatric Pharmacy Association (PPA).
  • Allie Taylor: New Faculty Scholar within Society of Teachers of Family Medicine.
  • Joshua Torres: Completion of Diploma of International Medicine and Public Health from the Institute of International Medicine (INMED).

Health Equity PRN

The Health Equity PRN warmly congratulates its members on their accomplishments. We look forward to implementing our educational, research, and mentorship initiatives. As the PRN expands, we also look forward to opportunities to collaborate and more ways to engage our members. Please reach out to us if you have any questions or ideas to promote health equity in our profession.

Promotions

  • Melissa Santibañez: Associate Professor, Department of Pharmacy Practice, Nova Southeastern University Barry and Judy Silverman College of Pharmacy, Davie, FL.

 Awards

  • Melissa Santibañez: Golden Apple Award, NSU College of Pharmacy, April 2025.
  • Daphne Smith Marsh: 2024-2025 Interprofessional Teacher of the Year, UIC Family Medicine Residency Program.

Grants

  • Sharmon P. Osae: 2025 Georgia Healthy Family Alliance Community Health Grant Award. Georgia Healthy Family Alliance. Co-Principal Investigator ($5000).
  • Daphne Smith Marsh: Improving Adherence to Guideline-Directed Medical Therapies in Patients with Type 2 Diabetes and Chronic Kidney Disease. National Kidney Foundation, Co-Investigator ($20,000).

 Publications

  • Nguyễn JV, Edwards DM, Egbunike-Chukwuma IG, Abdalla M, Santibañez M, Struewing M, Brotherton A, Connor SE, Krauss Z, Polisetty RS, Gosser RA. Best practices for the use of person-centered and inclusive language in clinical pharmacy practice, education, and research: an opinion paper and call to action from the American College of Clinical Pharmacy Health Equity Practice Research Network. J Am Coll Clin Pharm. 2025 Jul 30. [Epub ahead of print]. https://doi.org/10.1002/jac5.70093
  • Santibañez M. Critical care. In: Beckett RD, Bente JA, Bondi DS, et al, eds. Updates in Therapeutics®: Pharmacotherapy Preparatory Review and Recertification Course. American College of Clinical Pharmacy; 2025 (volume 2):295-356.
  • McAfee M, Rettele M, Santibañez M. Tenecteplase reversal in acute ischemic stroke: an overview and case report. SCCM Clinical Pharmacy and Pharmacology section newsletter. 2025;25(1, suppl 12.1):4-6.
  • Singh-Franco D, Santibañez M, Pham H, Metzner M, Hernandez-Toledo L. Resmetirom for moderate to advanced liver fibrosis. J Nurs Pract. 2025;21(5):105330. https://doi.org/10.1016/j.nurpra.2025.105330
  • Coffee A, Smith Marsh D, Elmes-Patel A. Additional comment on “Pharmacist-managed diabetes care and change in A1C: a retrospective matched cohort study.” J Am Coll Clin Pharm. 2025;8:320. https://doi.org/10.1002/jac5.70029

Presentations

  • Melissa Santibañez:
    • Impact of nimodipine dosing variation on neurological recovery and cerebral vasospasm incidence. Presented at: Florida Residency Conference; May 2025; Tampa, FL.
    • Systemic steroid dosing practices for acute exacerbations of chronic obstructive pulmonary disease. Presented at: SCCM Critical Care Congress; February 2025; Orlando, FL.
    • Evaluation of clinical outcomes of midodrine on IV vasopressor requirements in critically ill adults. Presented at: SCCM Critical Care Congress; February 2025; Orlando, FL.
  • Daphne Smith Marsh:
    • Pharmacist-mobile care clinic partnership to provide community-based health education & screenings in underserved communities. Poster presented at: American Pharmacists Association (APhA 25); March 2025; Nashville, TN.
    • Promoting equitable comprehensive diabetes care through an international pharmacy workshop. Poster presented at: Association of Diabetes Care & Education Specialists (ADCES25); August 2025; Phoenix, AZ.
    • Redefining obesity care: a comprehensive primary care workshop. Presenter and panelist. Presented at: Illinois Academy of Family Physicians; May 2025; virtual.
    • Integration of inclusive language in didactic and experiential instruction. Roundtable facilitator. Presented at: AACP Annual Meeting; July 2025; Chicago, IL.

 New ACCP Fellows

  • Sharmon P. Osae

 Other Notable Achievements

  • Jerika Nguyen: Education Committee Chair, SCCM Michigan Chapter.
  • Daphne Smith Marsh: Featured in Medscape May 2025 article “How Pharmacists and Primary Care Physicians Can Partner for Better Outcomes.”

Health Outcomes PRN

Awards

  • Jordan R. Covvey: Top 35 peer reviewer (2024), American Journal of Pharmaceutical Education.

Publications

  • Claus LW, Auten ME, Saseen JJ, Billups SJ. Guideline adherence of xanthine oxidase inhibitor utilization to treat gout in primary care. J Manag Care Spec Pharm. 2025;31(9):922-927. https://doi.org/10.18553/jmcp.2025.31.9.922
  • Billups SJ, Daffron A, Harty C, Lowe RN, Lobo I. Centralized outreach with embedded pharmacist e-consultation to reduce therapeutic inertia and improve blood pressure control. Am J Health Syst Pharm. 2025 Apr 25. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxaf096
  • Virrueta NA, Valdiviez V, Beutel T, Titus OJ, Peauroi S, Billups SJ. Pharmacist-supported electronic outreach to address medication nonadherence in Medicare Advantage enrollees. J Manag Care Spec Pharm. 2025;31(1):33-41. https://doi.org/10.18553/jmcp.2025.31.1.33
  • Worledge E, Billups SJ, Titus OJ, Saseen JJ. Achievement of low-density lipoprotein cholesterol thresholds in very high-risk atherosclerotic cardiovascular disease. J Clin Lipidol. 2025 Apr 11. [Epub ahead of print]. https://doi.org/10.1016/j.jacl.2025.04.186
  • Devraj R, Covvey JR, Arif SA. Bridging the digital divide: the importance of techquity in pharmacy education. Am J Pharm Educ. 2025;89(4):101308. https://doi.org/10.1016/j.ajpe.2025.101380
  • Gionfriddo MR, McClendon C, Nolfi DA, Kalarchian MA, Covvey JR. The importance of rigor in pharmacy research: challenges and solutions. Res Social Adm Pharm. 2025;21(5):424-430. https://doi.org/10.1016/j.sapharm.2025.02.005
  • Sifontis NM, Connor SE, Ho JAC, Morley S, O’Brien CE, Rotzenberg K, Varadarajan R, Covvey JR. A modified Delphi process to achieve consensus on social/administrative science topics in the pharmacy curriculum. Am J Pharm Educ. 2025;89(2):101349. https://doi.org/10.1016/j.ajpe.2024.101349
  • Lussier ME, Hamm ME, Kenkre BN, Wright EA, Gordon AJ, Wasan AD, et al. Clinician perceptions of electronic health record and email nudge interventions to prevent unsafe opioid prescribing: a qualitative study. J Opioid Manag. 2025;21(2):121-130. https://doi.org/10.5055/jom.0913
  • Lussier ME, Rattinger GB. Chapter 3: Cognitive decline and polypharmacy in long-term care. In: Health Promotion in Long-Term Care Facilities. Springer International Publishing; 2025.
  • Lucas RC, Govel JC, Nasta GN, Brooks M, Clark T, Johnston YA, Lussier ME, et al. Utilizing panel discussions to facilitate interprofessional learning: lessons from the rural and underserved service track. J Am Coll Clin Pharm. 2025;8:766-779. https://doi.org/10.1002/jac5.70074

 Presentations

  • Sarah J. Billups:
    • Revenue strategies: value-based revenue, billing for MA plans and incident-to billing. Presented at: American College of Clinical Pharmacy Ambulatory PRN Clinical Advancement webinar series; July 9, 2025; virtual.
    • Making patients healthier one millimeter of mercury at a time. Presented at: Tennessee Heart Health Learning Collaborative Webinar; July 29, 2025; virtual.
  • Jordan R. Covvey:
    • Elevating scholarship of teaching and learning: keys to academic publishing success: manuscript development. Presented at: DiPiro Workshop, AACP Annual Meeting; July 2025; Chicago, IL.
    • Practice makes perfect! The intersection of SAS and skills-based learning. Section presentation. Presented at: AACP; July 2025; Chicago, IL.
    • Comparison of reduced vs recommended cumulative doses of intravenous iron. Poster presented at: 2025 ACCP Virtual Poster Symposium; May 2025; virtual.

Hematology/Oncology PRN

Awards

  • Alexandre Chan: Oncology Pharmacy Practice Literature Award, 2025 HOPA Awards.
  • Donald Moore: Leadership Award, 2025 HOPA Awards.

Publications

Presentations and Media

  • Justin Arnall: Shifting the paradigm in hemophilia care: practical insights into integrating non‑factor therapies. Presented at: Clinical Care Options; May 16, 2025; virtual.
  • Amber Cipriani:
    • Precision medicine. Presented at: HOPA Oncology Case Series; May 29, 2025; virtual.
    • JHOP hot topics in oncology pharmacy. Presented at: ASCO 2025 Conference; June 2025; Chicago, IL.
  • Sarah Hayes: Cardio‑oncology in hematology. Presented at: International Academy for Clinical Hematology Weekly Webinar Series; February 2025; virtual.
  • Donald Moore: Real‑world incidence of infections in BCMA‑targeting bispecific antibodies in relapsed/refractory multiple myeloma. Presented at: ASCT & Cellular Therapy Tandem Meeting; February 2025; Honolulu, HI.

HIV PRN

Publications

  • Maguire C, Rueve K, Farmer E, Huesgen E, Karaj A, Binkley A, Mounzer K, Brizzi M, et al. Real world virologic outcomes in patients with elevated body mass index receiving long acting cabotegravir/rilpivirine. Clin Infect Dis. 2025;81(1):67-74. https://doi.org/10.1093/cid/ciae579

Infectious Diseases PRN

Promotions

  • Sarah Alghanem: Associate Professor, College of Pharmacy of Kuwait University.
  • Lee Nguyen: Health Sciences Clinical Professor, University of California Irvine School of Pharmacy and Pharmaceutical Sciences, Irvine, CA.
  • Hager Salaheldin: Deputy Head of Royal Medical Services, Clinical Pharmacy Department, Muharraq, Bahrain.

Awards

  • Rachel Britt: UTMB Health Residency Program Preceptor of the Year Award.
  • Elizabeth Covington: AACP Emerging Teaching Scholar Award.
  • Brandon Dionne: Northeastern University Bouvé College of Health Sciences Distinguished Educator Award – Graduate.
  • Carrie Freed: Preceptor of the Year, Cleveland Clinic Akron General.
  • Stephanie Harding: Preceptor of the Year, Wesley Medical Center.
  • Wes Kufel:
    • New York State Council of Health-System Pharmacists (NYSCHP) Research and Education Foundation Excellence in Pharmacy Practice Award.
    • State University of New York at Binghamton School of Pharmacy and Pharmaceutical Sciences Faculty Research and Scholarship Publication of the Year Award.
  • Rachel Musgrove: Georgia Society of Health-System Pharmacists Outstanding Practitioner of the Year.
  • Amanda Roy: Vincent G. Pons Award in Clinical Teaching, UCSF Department of Infectious Diseases.

 Grants

  • Elizabeth Covington: Pharmacist-Led Transitions of Care Intervention to Address Infectious Disease Tests Pending at Discharge (TPAD). Research Support Program. Auburn University ($50,000).

 Publications

  • Alqadi A, Almodyan E, Alanazi MN, Alghamdi SS, Ahmed MH, Badi S, et al. Vitamin D supplements and effect on glycemic control and lipid profile in individuals living with diabetes: a retrospective study. Eur Rev Med Pharmacol Sci. 2025;29(5):248-257. https://doi.org/10.26355/eurrev_202505_37223
  • Spellberg B, Wald-Dickler N, Holtom P, Meyer-Sautter P, Camp A, Diaz AD, Buhamad R, Vazquez ASM, Aguirre-Garcia GM, Stanton M, Butler-Wu SM, Chiu I, Ergenc Z, Bhoojhawon G, Murri R, Maraolo AE, Cabanilla G, Riccardi N, Tshisevhe V, Behenna C, Williams KS, Kufel WD, et al. Static vs. cidal: it’s not complex; it’s simply incorrect. Antimicrob Agents Chemother. 2025;69(8):e0051325. https://doi.org/10.1128/aac.00513-25
  • Covington EW, Kyle J, Moseley L. Scaffolding a clinical debate assignment in an infectious disease pharmacy elective: a mixed methods analysis. Curr Pharm Teach Learn. 2025;17(5):102306. https://doi.org/10.1016/j.cptl.2025.102306
  • Friend R, Willoughby T, Covington EW, Gunter SG. Comparing two-dose 1500 mg dalbavancin to standard of care in the outpatient treatment of invasive infections. Drugs Ther Perspect. 2025;41:220-226. https://doi.org/10.1007/s40267-025-01153-5
  • Vo QT, Noubary F, Dionne B, Doron S, Briesacher BA. County influenza vaccination rates and antibiotic prescribing rates in US nursing homes. Public Health Rep. 2025 Jul 5. [Epub ahead of print]. https://doi.org/10.1177/00333549251342746
  • Al Jabi S, El-Lababidi R, Abidi E, Afif C, El Nekidy WS. Clinical outcomes amongst patients infected with Candida auris: a single-center study. Mycoses. 2025;68(4):e70054. https://doi.org/10.1111/myc.70054
  • Funk OG, Khan R, Shah Z, Cusumano JA. Comparison of ceftriaxone versus ceftaroline in combination with ampicillin or penicillin against Enterococcus faecalis. Microbiol Spectr. 2025;13(6):e0271824. https://doi.org/10.1128/spectrum.02718-24
  • Govel JC, Seabury RW, Asiago-Reddy EA, Gutierrez RL, Parsels KA, Kufel WD. Evaluation of shorter versus longer antifungal treatment durations for Candida spp. urinary tract infections among hospitalized adults. Antimicrob Agents Chemother. 2025;69(6):e0192024. https://doi.org/10.1128/aac.01920-24
  • Gupta V, Satlin MJ, Yu KC, Martei Y, Sung L, Westblade LF, et al. Incidence and prevalence of antimicrobial resistance in outpatients with cancer: a multicentre, retrospective, cohort study. Lancet Oncol. 2025;26(5):620-628. https://doi.org/10.1016/S1470-2045(25)00128-7
  • Kufel WD, MacDougall C, Aitken SL, Dzintars K, Davis MR, Mahoney MV, Gallagher JC. Antimicrobial stewardship and beyond: the many essential roles of infectious diseases pharmacists. Clin Infect Dis. 2025;80(5):992-997. https://doi.org/10.1093/cid/ciaf106
  • Kufel WD, MacDougall C, Covington EW, Gallagher JC, Seabury RW, Steele JM. Reply: “Continuing the chat: how can we improve the performance of an artificial intelligence chatbot in answering clinical infectious diseases pharmacotherapy questions?” Open Forum Infect Dis. 2025;12(2):ofaf074. https://doi.org/10.1093/ofid/ofaf074
  • Kufel WD, Seabury RW, Spinler SA. Reply: “Impact of remdesivir on heart rate and bradycardia incidence among hospitalized adults with COVID-19.” Ann Pharmacother. 2025 Jul 5. [Epub ahead of print]. https://doi.org/10.1177/10600280251354862
  • Kufel WD, Zagoria ZJ, Seabury RW, Zeineddine N, Thomas SJ, Spinler SA, Steele JM. Impact of remdesivir on heart rate and bradycardia incidence among hospitalized adults with COVID-19. Ann Pharmacother. 2025 Apr 23. [Epub ahead of print]. https://doi.org/10.1177/10600280251327154
  • Kufel WD, Zeineddine N, Fouad A, Roenfanz HF, Shields RK, Kline EG, Warner J, Hanrahan K, Kuti JL. Pharmacokinetic and pharmacodynamic evaluation of sulbactam-durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex. Pharmacotherapy. 2025;45(7):396-402. https://doi.org/10.1002/phar.70027
  • Buyukyanbolu E, Argotsinger J, Beck ET, Chamberland RR, Clark AE, Daniels AR, Liesman R, Fisher M, Gialanella P, Hand J, Harrington AT, Humphries RM, Huse H, Hamilton-Seth R, Hankins JD, Kufel WD, Riddell SW, Marino J, Westblade LF, Mochon AB, Narayanan N, et al. Activity of ampicillin-sulbactam, sulbactam-durlobactam, and comparators against Acinetobacter baumannii-calcoaceticus complex strains isolated from respiratory and bloodstream sources: results from ACNBio study. Antimicrob Agents Chemother. 2025;69(8):e0037925. https://doi.org/10.1128/aac.00379-25
  • Davis MR, Kufel JE, Kufel WD, McCreary EK, Oleksiuk LM, Ours R, et al. You’ve got a friend in me: curbside questions infectious diseases clinicians ask infectious diseases pharmacists. Clin Infect Dis. 2025 May 15. [Epub ahead of print]. https://doi.org/10.1093/cid/ciaf250
  • Orlikowski C, Dumkow LE, Schmidt KJ, Jameson AP. Evaluating risk factors for short versus long hospital stay for cellulitis to guide the development of a long-acting lipoglycopeptide use decision algorithm. Ann Pharmacother. 2025 Jul 26. [Epub ahead of print]. https://doi.org/10.1177/10600280251355631
  • Tong DMH, Hughes MSA, Hu J, Pearson JC, Kubiak DW, Dionne BW, et al. Comparing two-sample log-linear exposure estimation with Bayesian model-informed precision dosing of tobramycin in adult patients with cystic fibrosis. Antimicrob Agents Chemother. 2025;69(2):e0104024. https://doi.org/10.1128/aac.01040-24
  • Salah H, Rabea H, Sheemy MS, Rabie AI, Moustafa HAM, Elberry AA, et al. Targeting insulin-like growth factor-1 (IGF-1) by using metformin in non-diabetic metastatic breast cancer female patients: a randomized controlled trial. Cancer Chemother Pharmacol. 2025;95(1):64. https://doi.org/10.1007/s00280-025-04791-8
  • Mohamed AG, Badawy HF, Said ASA, Al-Ahmad MM, Rabie ASI, Salah H, et al. Additive value of pyridostigmine to silodosin in the management of acute urinary retention secondary to benign prostatic hyperplasia: a randomized controlled trial. J Clin Med. 2025;14(3):674. https://doi.org/10.3390/jcm14030674
  • Vance MK, Cimino C, Fiske C, Onguti S. Sternal osteomyelitis caused by Mycobacterium phlei: case report and literature review of a rarely pathogenic nontuberculous mycobacterium. AIMCC. 2025;4(4):e240444. https://doi.org/10.7326/aimcc.2024.0444
  • Smith DJ, Misas E, Gold JAW, Evert N, Dang T, Prot E, Godwin S, Rivas J, Pearson J, Koenecke L, Bustamante ND, Marinissen MJ, Rodriquez GG, López-Martínez I, Lutfy C, Williams S, Vazquez Deida AA, Byrd KM, Villalba JA, Reagan-Steiner S, Parnell L, Gade L, Humphries RM, Wiederhold NP, et al. Fungal meningitis in U.S. patients who received epidural anesthesia in Matamoros, Mexico. Clin Infect Dis. 2025 Jul 22. [Epub ahead of print]. https://doi.org/10.1093/cid/ciaf399
  • Wong A, Flanagan T, Covington EW, Nguyen E, Linn D, Brummel G, Hoffmaster B, Isaacs D, Kane-Gill SL. Forecasting the impact of artificial intelligence on clinical pharmacy practice. J Am Coll Clin Pharm. 2025;8(4):302-310. https://doi.org/10.1002/jac5.70004

Presentations

  • Elizabeth Covington: Penicillin allergy clarifications in resource limited settings. Presented at: Association for Professionals in Infection Control and Epidemiology (APIC), Maine Chapter; February 2025; virtual.
  • Jaclyn Cusumano: The rise of enterococcal endocarditis: a sticky situation. Presented at: ASM Microbe; June 22, 2025; Los Angeles, CA.
  • Vikas Gupta:
    • Impact antimicrobial resistance has on cancer patients. Presented at: ASM Microbe; June 22, 2025; Los Angeles, CA.
    • Lounge and learn on cancer and antimicrobial resistance (AMR). Presented at: ASM Microbe; June 2025; Los Angeles, CA.
    • Roundtable: How AMR threatens cancer care. Presented at: AMR Insights; June 25, 2025; virtual.
  • Wes Kufel: Let’s have a chat: how well does an artificial intelligence chatbot answer clinical infectious diseases pharmacotherapy questions? Presented at: New York State Council of Health-System Pharmacists Annual Assembly; April 4, 2025; Saratoga Springs, NY.
  • Rachel Musgrove: PO or NO-Go: the great staph step-down showdown. Presented at: GSHP 2025 Summer Meeting; July 11, 2025; Amelia Island, FL.
  • Hager Slaheldin: Antimicrobial use in palliative and end-of-life care: balancing ethics, comfort, dignity, and stewardship. Presented at: ID Academic Training Program RMS hospitals; June 2025; Al Saya, Bahrain, Gulf Cooperation Council area.

New ACCP Fellows

  • Wes Kufel

Other Notable Achievements

  • Entisar Almodyan: Certification for Medication Therapy Management Professional (CMTMP), Saudi Society for Clinical Pharmacy.
  • Brandon Dionne: Fellow, Infectious Diseases Society of America (FIDSA).
  • Wes Kufel:
    • Infectious Diseases Pharmacist Consultant, New York State Department of Health Bureau of Healthcare Associated Infections Antimicrobial Resistance Surveillance and Response Program.
    • Appointed to Editorial Board, Journal of the American College of Clinical Pharmacy.
    • Fellow, Infectious Diseases Society of America (FIDSA).
  • James Sanders: Fellow, Surgical Infection Society (FSIS).

Nephrology PRN

Promotions

  • Sarah Alghanem: Associate Professor, College of Pharmacy of Kuwait University.
  • Haley N. Johnson: Associate Professor, St. Louis College of Pharmacy at University of Health Sciences and Pharmacy.

Awards

  • Timothy Nguyen:
    • David Newton Awards for Excellence in Teaching (2025), Long Island University.
    • Faculty Preceptor of the Year Award, Long Island University.

Publications

  • Abidi E, Afif C, Al Jabi S, El-Lababidi R, El Nekidy WS. Clinical outcomes amongst patients infected with Candida auris: a single-center study. Mycoses. 2025;68(4):e70054. https://doi.org/10.1111/myc.70054
  • Abidi E, Al Sayegh L, Dajani RZ, El-Kaissi S, El Nekidy WS, Hegazin SB, et al. Comparing the efficacy of liraglutide and semaglutide on weight loss: experience from the Middle East Gulf Region and literature review. Hosp Pharm. 2025 May 21. [Epub ahead of print]. https://doi.org/10.1177/00185787251340645
  • Manis MM, Wallace JL, Boyd EF, Kaleab ZA, Fried L, Palevsky PM, Conway PT, Horwitz EJ, Liu KD, Parikh CR, Poggio E, Siew ED, Neyra JA, Weir MR, Wilson FP, Kane-Gill SL. Postdischarge care of acute kidney injury survivors: an opportunity for targeted nurse and pharmacist interventions. Adv Kidney Dis Health. 2025;32(2):154-161. https://doi.org/10.1053/j.akdh.2025.01.00
  • Khan RW, St. Peter WL. Comment on “Establishing discordance rate of estimated glomerular filtration rate between serum creatinine-based calculations and cystatin-C-based calculations in critically ill patients.” Pharmacotherapy. 2025;45:468-469. https://doi.org/10.1002/phar.70034
  • Downes E, Khan RW. Green house region: tubular toxins versus oxalate offenders. NephMadness 2025 AJKDblog. Posted March 1, 2025. https://ajkdblog.org/2025/03/01/nephmadness-2025-green-house-region/
  • Pincus KJ, Khan RW. Chapter 100: Thyroid disorders. In: Haines ST, Nolin TD, Ellingrod VL, Posey L, Cocohoba J, Holle L, eds. Pharmacotherapy: A Pathophysiologic Approach. 13th ed. McGraw-Hill; 2025.
  • Aistrope D, Maxson R, Neumiller JJ, Weltman MR, Chow S. Cardiovascular-kidney-metabolic syndrome medications: a time to rebrand? Am J Health Syst Pharm. 2025;82(12):738-744. https://doi.org/10.1093/ajhp/zxaf042
  • Nguyen T. Medications for cardiovascular disease and glucose care. J Nurse Pract. 2025;21(7):105407. https://doi.org/10.1016/j.nurpra.2025.105407
  • Nguyen T, Lin H, Tint D, Dima L, Wang Z. Aprocitentan: the first endothelin receptor antagonist for resistant hypertension. Am J Ther. 2025 Jul 11. [Epub ahead of print]. https://doi.org/10.1097/MJT.0000000000001950
  • Chua H, Nguyen T. Reducing polypharmacy and patient harm: use of medication screening tools supports the detection and prevention of adverse drug events. J Nurse Pract. 2025;21(9):105490. https://doi.org/10.1016/j.nurpra.2025.105490
  • Marzella N, Kish T, Costinas C, Dima L, Nguyen T. Sulbactam-durlobactam for carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex infections. Am J Ther. 2025;32(2):e151-158. https://doi.org/10.1097/MJT.0000000000001934
  • Alghwiri AA, Chen YF, Han Z, Jhamb M, Lavenburg LU, Nolin TD, Weltman MR, Yabes JG. Using machine learning to predict medication therapy problems among patients with chronic kidney disease. Am J Nephrol. 2025 Jun 17. [Epub ahead of print]. https://doi.org/10.1159/000546540
  • Chan C, Good C, Jhamb M, Kogan J, Nolin TD, Paley C, Rollman B, Suh K, Weltman MR, Yabes JG, Yang J. Population health management impact on healthcare utilization and costs in CKD: post hoc analysis of the Kidney Coordinated HeAlth Management Partnership Trial. Clin J Am Soc Nephrol. 2025;20(8):1063-1071. https://doi.org/10.2215/cjn.0000000754
  • St. Peter WL, Bzowyckyj AS, Anderson-Haag T, Awdishu L, Blackman M, Bland A, et al. Moving forward from Cockcroft-Gault creatinine clearance to race-free estimated glomerular filtration rate to improve medication-related decision-making in adults across healthcare settings: a consensus of the National Kidney Foundation Workgroup for Implementation of Race-Free eGFR-Based Medication-Related Decisions. Am J Health Syst Pharm. 2025;82(12):644-659. https://doi.org/10.1093/ajhp/zxae317
  • Hillman L, Warfield C, St. Peter WL. Perspectives of medication-related experiences in Black persons with kidney diseases: the patient voice. Am J Health Syst Pharm. 2025;82(12):710-718. https://doi.org/10.1093/ajhp/zxaf043
  • Weltman MR, Han Z, Lavenburg LU, Alghwiri AA, Yabes JG, Nolin TD, et al. Effect of a population health management intervention on medication therapy problems in people with chronic kidney disease: post hoc analysis of the K-CHAMP cluster randomized trial. Kidney Med. 2025;7(5):100995. https://doi.org/10.1016/j.xkme.2025.100995
  • Jhamb M, Schell JO, Weltman MR, Lavenburg LU, Puttarajappa C, Fischer GS. Population health management for improving kidney health outcomes. Am J Kidney Dis. 2025;86(2):263-271. https://doi.org/10.1053/j.ajkd.2025.01.020
  • Lavenburg LU, Devaraj SM, Gul A, Weltman MR, Kenkre BN, Cameron FA, et al. Patient perceptions of a population health management program to improve kidney care: optimizing care in CKD. Kidney Med. 2025;7(7):101025. https://doi.org/10.1016/j.xkme.2025.101025

 Presentations

  • Downes E, Khan R, King J, Vinnikova A. Leafy greens & injured beans: nature’s nephrotoxins. Episode 36. Presented at: The Poison Lab Podcast; March 1, 2025; virtual.
  • Wendy St. Peter:
    • Integrating the “K” into CKM syndrome. Presented at: Tennessee Diabetes Learning Collaborative; March 5, 2025; virtual.
    • Move over C-G eCrCL! CKD-EPI for drug-related decision-making. Presented at: National Kidney Foundation Spring Clinical Meeting; April 2025; Boston, MA.
    • A sea change in the treatment of kidney disease in diabetes. Presented at: American Diabetes Association 85th Annual Meeting; June 22, 2025; Chicago, IL.
    • One size does not fit all: pharmacist perspective on using eGFR for drug-related decision making. Presented at: Association for Diagnostics & Laboratory Medicine conference; July 28, 2025; Chicago, IL.
    • Goodbye to Cockcroft-Gault … hello CKD-EPI. Presented at: Faculty of Western University College of Pharmacy; August 19, 2025; virtual.

 ACCP Fellows

  • Rachel W. Khan

Pediatrics PRN

Promotions

  • Luke Orth: Associate Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences.

Awards

  • Luke Orth: Chancellor’s Teaching Award, University of Colorado Anschutz Medical Campus.

Grants

  • Kari Allan and Luke Orth: Expansion of Clinical Pharmacy Services for Children and Youth with Special Healthcare Needs in a Predominately Medicaid-Serviced Population (renewed). Funding Agency: CO Department of Health Care Policy and Finance. Primary Investigator ($169,198). July 2024 to June 2025.
  • Hanna Phan: Lumeng CN, Phan H. Health Resources and Services Administration (HRSA), Pediatric Pulmonary Center Grant. $1.7 million over 5 years (2025-2030).

 Publications

  • Bradley JS, Harvey H, Stout D, Momper J, Capparelli E, Avedissian SN, et al. Subtherapeutic meropenem antibiotic exposure in children with septic shock assessed by noncompartmental pharmacokinetic analysis in a prospective dataset. Pediatr Crit Care Med. 2025;26(4):e507-e515. https://doi.org/10.1097/PCC.0000000000003698
  • Cressey TR, Salvadori N, Rabie H, du Toit S, Than-In-At K, Groenewald M, Capparelli E, et al. Single doses of pediatric dolutegravir dispersible tablets in neonates support multidosing: PETITE-dolutegravir study. J Acquir Immune Defic Syndr. 2025;99(2):195-201. https://doi.org/10.1097/QAI.0000000000003652
  • Le J, Huynh J, Vo B, Mai A, Mak RH, Momper JD, Capparelli EV, et al. Variability in meropenem distribution and clearance in children with sepsis: population-based pharmacokinetics with assessment of renal biomarkers. Clin Pharmacokinet. 2025;64(5):769-777. https://doi.org/10.1007/s40262-025-01495-3
  • Moore CB, Baltrusaitis K, Best BM, Moye JH, Townley E, Violari A, Heckman B, Buisson S, Van Solingen-Ristea RM, Capparelli EV, et al. Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study. Lancet HIV. 2025;12(3):e191-e200. https://doi.org/10.1016/S2352-3018(24)00344-8
  • Wolff J, Cober MP, Huff KA. Essential fatty acid deficiency in parenteral nutrition: historical perspective and modern solutions, a narrative review. Nutr Clin Pract. 2025;40(2):350-367. https://doi.org/10.1002/ncp.11278
  • Tabulov CE, Mui A, Gargasz AE, Shaeer KM. Rifampin induced ataxia and clonus in an adolescent male hemodialysis patient: a case report. Hemodial Int. 2025 May 26. [Epub ahead of print]. https://doi.org/10.1111/hdi.13260
  • Johnson PN, Ropp DL, Ranallo C, Chaaban H, Garcia-Contreras L, Neely SB, Miller JL. Inhaled tobramycin utilization in critically ill pediatric patients without cystic fibrosis: a Pediatric Pharmacy Association Practice-Based Research Network Survey Study. J Pediatr Pharmacol Ther. 2025;30(3):332-339. https://doi.org/10.5863/JPPT-24-00061
  • Chang E, Parman A, Johnson PN, Stephens K, Neely SB, Dasari N, et al. Correspondence on “gabapentin for delirium in the neonatal intensive care unit.” [Authors’ response to letter]. J Pediatr Pharmacol Ther. 2025;30:298-301. https://pmc.ncbi.nlm.nih.gov/articles/PMC12288565/
  • Johnson PN, Miller JL, Makoni M. Response to commentary: “Vasopressin induced hyponatremia in infants <3 months of age in the neonatal intensive care unit.” Front Pediatr. 2025 Apr 9. [Epub ahead of print]. https://doi.org/10.3389/fped.2025.1571691
  • Goldstone LW, Johnson PN, Fliehman D, Hayes K, Taylor S, Van Devender EA, et al. Supporting resident well-being: considerations for residency program directors and pharmacy enterprise leadership. Am J Health Syst Pharm. 2025 Apr 30. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxaf100
  • Lee CKK, Johnson PN. Pharmacy practice for therapeutic orphans: current and future reflections for pediatric pharmacy. Am J Health Syst Pharm. 2025 Mar 22. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxaf073
  • Orth LE. Autism spectrum disorder. In: Sanoski CA, Witt DM, eds. Pharmacotherapy Self-Assessment Program, 2025 Book 3. Behavioral Health and Pediatrics. American College of Clinical Pharmacy; 2025. In press.
  • Orth LE, Allan K, EL Ross, Lemons A. Concern for patient harm due to potentially supratherapeutic clonidine dosing resulting from physiologically based pharmacokinetic modeling. J Pediatr Pharmacol Ther. 2025;30(3):414-417. https://doi.org/10.5863/jppt-25-00023
  • Begum A, Hosokawa P, Orth LE, Feinstein JA. Annual medication use and costs among children. JAMA Netw Open. 2025;8(3):e251529. https://doi.org/10.1001/jamanetworkopen.2025.1529
  • Sierra CM, Capino AC, Cober MP, Eiland LS, Fenn NE, Fusco NM, Orth LE. Incorporating pediatrics in clinical education: a call to action in inpatient pharmacy practice. J Pediatr Pharmacol Ther. 2025;30(1):4-7. https://doi.org/10.5863/1551-6776-30.1.4

Presentations

  • Edmund Capparelli: Pharmacokinetics and safety considerations for long-acting therapeutics: use in children. Presented at: University of Liverpool UK, Centre of Excellence for Long-Acting Therapeutics (CELT) Conference; July 1; Liverpool, UK.
  • M. Petrea Cober, Lea Eiland, Norm Fenn, Luke Orth, Caroline Sierra: Innovative APPE development and integration. Presented at: AACP’s AACP Learn Education Series; June 25, 2025; virtual.
  • Brent Hall: Artificial intelligence (AI) in residency applications—game changer or system vulnerability? Presented at: ASHP Pharmacy Futures Meeting; June 10, 2025; Charlotte, NC.
  • Emma Matherne:
    • Prolonged neuromuscular blockade in acute kidney injury. Presented at: Pediatric Pharmacy Association Annual Meeting; April 2025; Portland, OR.
    • Status epilepticus ketamineus. Presented at: Pediatric Pharmacy Association Annual Meeting; April 2025; Portland, OR.
  • Luke Orth:
    • It’s elementary! Pearls to optimize the pediatric medication use process. Presented at: Colorado Pharmacists Association Annual Meeting; June 2025; Colorado Springs, CO.
    • Keeping track of it all: a grounded theory study of how caregivers manage polypharmacy in children with medical complexity. Presented at: Pediatric Academic Societies Annual Meeting; April 2025; Honolulu, HI.
    • Assessing the need for interventions to manage pediatric polypharmacy using an all-payer claims database. Presented at: Pediatric Academic Societies Annual Meeting; April 2025; Honolulu, HI.

 Other Notable Achievements

  • Kim Benner: ASHP President-Elect (2025-2026).
  • Petrea Cober: Graduated with a Master of Education degree (MEd) in Health Professions Education from Cleveland State University.
  • Dominique Mark:
    • 2025-2025 ACCP Professional Leadership Development Program.
    • Incoming PediPRN Chair for 2026-2027 cycle.
  • Emma Matherne: Leadership Position: Pediatric Pharmacy Program Coordinator- Virtual Pharmacy Services Southeast Region at Atrium Health.
  • Gary Milavetz: 2025 Keynote Commencement Address to the University of Minnesota College of Pharmacy Graduating Class.
  • Hanna Phan:
    • Pediatric Pharmacy Association, 2025 Richard A. Helms Award of Excellence in Pediatric Pharmacy Practice. Accompanying Lecture delivered, “Childhood Stories to Grown-Up Reflections” at the 2025 Annual Conference.
    • New leadership role—Associate Director, University of Michigan Pediatric Pulmonary Center (PPC) Training Program.
  • Mike Raschka:
    • Young Alumnus of the Year 2025 from University of Wisconsin School of Pharmacy.
    • 2025 Substance Use Treatment Innovator Award from Minnesota Hospital Association (Awarded to Children’s Minnesota Substance Disorder Team).

Perioperative Care PRN

Publications

  • Ebbitt LM. Cross-sectional survey of critical care pharmacy residency programs: post-residency positions acquired and job market perceptions. J Am Coll Clin Pharm. In press.
  • Ebbitt LM, VanHoose JD, Manci S, Schadler A, Leonhard A, Patel JA. Financial and clinical toxicity of empiric vancomycin for intra-abdominal infections: a cohort study. Surg Infect. 2025 May 29. [Epub ahead of print]. https://doi.org/10.1089/sur.2024.269
  • Hyland SJ, Eaton RE, Max ME, et al. Pharmacotherapy of acute ST-elevation myocardial infarction and the pharmacist’s role, part 1: Patient presentation through revascularization. Am J Health Syst Pharm. 2025;82(13):e578-595. https://doi.org/10.1093/ajhp/zxae303
  • Hyland SJ, Max ME, Eaton RE, et al. Pharmacotherapy of acute ST-elevation myocardial infarction and the pharmacist’s role, part 2: Complications, post-revascularization care, and quality improvement. Am J Health Syst Pharm. 2025;82(14):775-805. https://doi.org/10.1093/ajhp/zxae310
  • Linn DD, Rech MA, Faine BA. Strategies to prevent awareness with paralysis following administration of neuromuscular blocking agents. Am J Health Syst Pharm. 2025 Mar 22. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxaf072
  • Renew JR, Linn DD. Pro: The use of sugammadex does not preclude the need for objective neuromuscular monitoring. J Cardiothorac Vasc Anesth. 2025;39(7):1878-1881. https://doi.org/10.1053/j.jvca.2025.04.001
  • Wolfe R. Rescue agents for perioperative vasoplegia. J Perianesth Nurs. 2025;40(2):454-456. https://doi.org/10.1016/j.jopan.2025.01.019
  • Wolfe R. Perioperative hyperkalemia and post-treatment hypoglycemia. J Perianesth Nurs. 2025;40(4):1069-1071. https://doi.org/10.1016/j.jopan.2025.05.024

Presentations

  • Rachel Wolfe:
    • The ABCs of MICs: interpreting minimum inhibitory concentration and antibiotic breakpoints. A line in the sand: antibiotic breakpoints in critically ill patients. Presented at: SCCM; February 2025; Orlando, FL.
    • Periprocedural management. Presented at: Nova Southeastern University Critical Care Symposium; March 2025; Fort Lauderdale, FL.
    • Perioperative carbohydrate loading—is it safe in patients with diabetes mellitus undergoing colorectal surgery? Presented at: Quality and Safety Conference; July 2025; San Diego, CA.

 Other Notable Achievements

  • Laura Means Ebbitt: Fellow of Critical Care Medicine (FCCM), Society of Critical Care Medicine.

Pharmacokinetics/Pharmacodynamics/Pharmacogenomics PRN

Promotions

  • Sarah Alghanem: Associate Professor, College of Pharmacy at Kuwait University.
  • Jacob Brown: Associate Professor with Tenure, University of Minnesota College of Pharmacy.
  • Jason Karnes: Professor, Department of Pharmacy Practice and Science, University of Arizona R. Ken Coit College of Pharmacy, Phoenix and Tucson, AZ.
  • Amy L. Pasternak: Clinical Associate Professor, University of Michigan College of Pharmacy.
  • D. Max Smith: Associate Professor, Georgetown University Medical Center.
  • James M. Stevenson: Associate Professor of Medicine, Physiology, Pharmacology and Therapeutics, Johns Hopkins University School of Medicine.

Awards

  • Roseann S. Donnelly:
    • Innovation in Pharmacogenomics Teaching Award, American Association of Colleges of Pharmacy—Pharmacogenomics Special Interest Group.
    • Excellence in Interprofessional Collaborative Practice Award, American Association of Colleges of Pharmacy—Pharmacy Practice.
  • James M. Stevenson: Robert Feroli Award for Excellence in Medication Safety, Johns Hopkins Medicine.

Publications

  • Jacobson PA, Johnson ANK, Bishop JR, Baye J, Petry NJ, Bright DR, Brown JT, et al. Pharmacogenomics case-based education: establishment of an Extension for Community Health Outcomes (ECHO) education model for healthcare professionals. Am J Health Syst Pharm. 2025 Jun 9. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxaf141
  • Caudle KE, Whirl-Carrillo M, Relling MV, Hoffman JM, Donnelly RS, Haidar CE, et al. Advancing clinical pharmacogenomics worldwide through the Clinical Pharmacogenetics Implementation Consortium (CPIC). Clin Pharmacol Ther. 2025 Jul 18. [Epub ahead of print]. https://doi.org/10.1002/cpt.70005
  • Donnelly RS, Ayoubieh H, Kudron EL, Mills R, Weiler T, Empey PE. When patients present with direct-to-consumer pharmacogenomic test results. Mayo Clin Proc. 2025;100(2):197-203. https://doi.org/10.1016/j.mayocp.2024.10.016
  • Donnelly RS, Kerman BK, Fieg E. Intentional interprofessional experiential education in clinical pharmacogenomics for pharmacy and genetic counseling students. J Am Coll Clin Pharm. 2025 Jun 24. [Epub ahead of print]. https://doi.org/10.1002/jac5.70069
  • Cropp CD, Gálvez-Peralta M, Ham AL, Hoger JD, Ward KM, Norris M, Petry NJ, Roosan MR, Donnelly RS, et al. Development of a pharmacogenomics case repository for pharmacy educators. Am J Pharm Educ. 2025;89(6):101397. https://doi.org/10.1016/j.ajpe.2025.101397
  • Maska L, Donnelly RS, Kerman BJ, Cirino A, Fieg E. Patient perspectives of a multidisciplinary pharmacogenomics clinic. Pharmacogenomics. 2025;26(1-2):9-21. https://doi.org/10.1080/14622416.2025.2481016
  • Ghisays V, Khajouei E, Piras IS, Malek-Ahmadi MH, Protas HD, Goradia DG, Chen Y, Naymik M, Saner D, Veatch OJ, Mansel CO, Su Y, Huentelman MJ, Karnes JH, et al. Impact of APOE4-related dementia risk in underrepresented groups from the All of Us research program. Alzheimers Dement. 2025;21(6):e70245. https://doi.org/10.1002/alz.70245
  • Khajouei E, Ghisays V, Piras IS, Martinez KL, Vicenti AT, Naymik M, Ngo P, Tran TC, Denny JC, Wheeler TJ, Huentelman MJ, Reiman EM, Karnes JH. Phenome-wide association of APOE alleles in the All of Us research program. eBioMedicine. 2025;117:105768. https://doi.org/10.1016/j.ebiom.2025.105768
  • Tafazoli A, Hemmati M, Rafigh M, Alimardani M, Khaghani F, Korostynski M, Karnes JH. Leveraging long-read sequencing technologies for pharmacogenomic testing: applications, analytical strategies, challenges, and future perspectives. Front Genet. 2025;16:1435416. https://doi.org/10.3389/fgene.2025.1435416
  • Massmann A, Baye J, Weaver M, Petry N, Jacobsen K, Schultz A, Brady H, Van Heukelom J. Impact of a pharmacogenomics (PGx) clinic on patient satisfaction and PGx literacy. Pharmacogenomics. 2025;26(1-2):23-29. https://doi.org/10.1080/14622416.2025.2481015
  • Massmann A, Petry N, Mills S, Adjekum A, Van Heukelom J. Impact of using dosing criteria to refine pharmacogenomic clinical decision support for tricyclic antidepressants. Am J Health Syst Pharm. 2025;82(9):e457-e464. https://doi.org/10.1093/ajhp/zxae337
  • Nguyen J, Paetznick C, Donnelly RS. Hereditary pseudocholinesterase deficiency and succinylcholine: historical perspective, therapeutic implications, and future considerations. Pharmacotherapy. 2025 Aug 8. [Epub ahead of print]. https://doi.org/10.1002/phar.70048
  • Barq RM, Ourshalimian S, Maggo S, Keane OA, Nguyen JQ, Deardorff MA, et al. Opioid-related pharmacogenomic variants in a retrospective cohort of high-risk hospitalized infants. J Pediatr. 2025 Jul 17. [Epub ahead of print]. https://doi.org/10.1016/j.jpeds.2025.114725
  • Maggo S, Nguyen JQ, Gong CL. Economic analysis of pharmacogenomics: challenges and progress. Adv Mol Pathol. 2025 Jul 4. [Epub ahead of print]. https://doi.org/10.1016/j.yamp.2025.05.006
  • Maggo S, Pan Y, Ostrow D, Nguyen JQ, Biegel JA, Deardorff MA, et al. Clinical impact of pharmacogenomics in pediatric care: insights extracted from clinical exome sequencing. Front Genet. 2025;16:1574325. https://doi.org/10.3389/fgene.2025.1574325
  • Maillard M, Nguyen JQ, Yang W, Hoshitsuki K, Relling MV, Caudle KE, et al. Clinical actionability of the NUDT15 *4 (p.R139H) allele and its association with Hispanic ethnicity. Clin Pharm Ther. 2025;117(3):724-731. https://doi.org/10.1002/cpt.3501
  • Smith DM, Douglas MP, Aquilante CL, Dverka PA, Devine B, Dunnenberger HM, et al. Progress in pharmacogenomics implementation in the United States: barrier erosion and remaining challenges. Clin Pharmacol Ther. 2025 Jun 4. [Epub ahead of print]. https://doi.org/10.1002/cpt.3736
  • Stranges PM, Adams KK, Alharir A, Burnam LG, Elmes-Patel AT, Greenlee SB, Infante AF, Kerins A, Ma Q, Meyenburg LK, Nyman C, Peters GL, Rambaran K, Smith DM, et al. Pharmacists’ contributions to the management of opioid use disorder. J Am Coll Clin Pharm. 2025;8(6):413-516. https://doi.org/10.1002/jac5.70049
  • Stevenson JM, Smith DM, Tuteja S, Patel JN; Pharmacogenomics Global Research Network (PGRN) Publications Committee. Navigating pharmacogenomic testing in practice: who to test and when to test. Clin Pharmacol Ther. 2025;118(3):561-566. https://doi.org/10.1002/cpt.3704
  • Cung M, Loftus J, Marzinke MA, Stevenson JM. Reinterpretation of pharmacogenomic phenotypes after combinatorial psychiatric testing. Pharmacogenomics. 2025;26(1-2):1-7. https://doi.org/10.1080/14622416.2025.2479409
  • Tuteja S, Cayabyab MAS, Hoffecker G, Varughese LA, Ndayishimiye JD, Wittner VA, et al. Implementation of DPYD and UGT1A1 testing in patients with GI cancer: a prospective, nonrandomized clinical trial. JCO Prec Oncol. 2025;9:e2500086. https://doi.org/10.1200/PO-25-00086
  • Tuteja S, O’Brien WJ, Ferraro JP, Damrauer SM, Itani KMF, Voight BF, et al. Gene interactions and clinical outcomes after vascular surgery in the Million Veteran Program (MVP). JAMA Surg. 2025;160(7):804-813. https://doi.org/10.1001/jamasurg.2025.1503
  • Chanfreau-Coffinier C, Friede KA, Plomondon ME, Lee KM, Lu Z, Dinatale T, DuVall SL, Vassy JL, Waldo SW, Cleator JH, Maddox TM, Rader DJ, Assimes TL, Damrauer SM, Tsao PS, Chang KM, Voora D, Lynch JA, Giri J, Tuteja S. CYP2C19 polymorphisms and clinical outcomes following percutaneous coronary intervention in the Million Veterans Program. Clin Pharmacol Ther. 2025 Jun 3. [Epub ahead of print]. https://doi.org/10.1002/cpt.3741
  • Hoffecker G, Keat K, Mulugeta-Gordon L, Risman M, Verma SS, Deagostino-Kelly M, Tuteja S. Feasibility of pharmacogenetic-guided selection of postoperative analgesics in gynecologic surgery patients: a prospective, randomized, pilot study. Pharmacogenet Genomics. 2025;35(6):183-191. https://doi.org/10.1097/FPC.0000000000000568
  • Yang G, Alarcon C, Chanfreau C, Lee NH, Friedman P, Nutescu E, Tuck M, O’Brien T, Gong L, Klein TE, Chang KM, Tsao PS, Meltzer DO, Lynch JA; Million Veteran Program; Tuteja S, et al. Investigation of genomic and transcriptomic risk factors of clopidogrel response in African Americans. Clin Pharmacol Ther. 2025;117(5):1313-1324. https://doi.org/10.1002/cpt.3552
  • Zhang L, Ivleva EI, Parker DA, Hill SK, Lizano P, Keefe RSE, et al. Impact of polygenic interactions with anticholinergic burden on cognition and brain structure in psychosis spectrum disorders. Am J Psychiatry. 2025;182(8):751-762. https://doi.org/10.1176/appi.ajp.20240709
  • Zhang L, Tholkes AJ, Jones KC, Yang LJ, Sieger GK, Mroz P, et al. Real-world characterization of psychiatric pharmacogenomic test ordering and clinical relevance in adults and children. Clin Transl Sci. 2025. In press.
  • Zhang L, Yang C, Zhang W, Lui S, Bishop JR. Human leukocyte antigen (HLA) class I and II genetic relationships with brain imaging measures: a systematic review and meta-analysis. Brain Behav Immun. 2025;128:336-351. https://doi.org/10.1016/j.bbi.2025.04.011
  • Yang C, Zhang L, Liu J, Li S, Gong Q, Yang Z, et al. More severe brain network hierarchy disorganization in treatment-naïve deficit compared to non-deficit schizophrenia and underlying neurotransmitter associations. Schizophr Bull. 2025 Jun 20. [Epub ahead of print]. https://doi.org/10.1093/schbul/sbae231

New ACCP Fellows

  • Sony Tuteja

Pulmonary PRN

Promotions

  • Hanna Phan: Associate Director, University of Michigan Pediatric Pulmonary Center (PPC) Training Program.
  • Melissa Santibañez: Associate Professor, Department of Pharmacy Practice, NSU Barry and Judy Silverman College of Pharmacy, Fort Lauderdale, FL.

Awards

  • Paul Boylan:
    • Teacher of the Year, The University of Oklahoma College of Pharmacy.
    • Outstanding Preceptor, The University of Oklahoma College of Pharmacy.
  • Kimmy Nguyen: 2025 Preceptor of the Year, Pennsylvania Pharmacists Association.
  • Hanna Phan: Richard A. Helms Award of Excellence in Pediatric Pharmacy Practice, Pediatric Pharmacy Association (PPA), 2025.
  • Melissa Santibañez:
    • Golden Apple Award Winner, NSU College of Pharmacy (overall winner and class of 2025 nominee), Fort Lauderdale, FL, April 2025.
    • SCCM Presidential Citation Award, SCCM Critical Care Congress, Orlando, FL, February 2025.

Grants

  • Hanna Phan: Lumeng CN, Phan H. Health Resources and Services Administration (HRSA), Pediatric Pulmonary Center Grant. $1.7 million over 5 years (2025-2030).

Publications

  • Martirosov AL, Abdalla M, Fleischman M, Foster B, Gonzales J, Lipari M, Malesker M, Smith Z, Wilken L, Williams D. Navigating the alphabet soup of interstitial lung diseases (ILD): the role of pharmacists. J Am Coll Clin Pharm. 2025 Jul 27. [Epub ahead of print]. https://doi.org/10.1002/jac5.70089
  • Boylan PM. Case series: Upper respiratory tract infections. In: Irons B, Meredith AH, eds. Ambulatory Care Self-Assessment Program, 2025 Book 1. Pulmonary Care. American College of Clinical Pharmacy; 2025:29-58.
  • Boylan PM, Dennis V, Neely S, Skrepnek G. Experience using a state board of pharmacy adequate staffing form: a descriptive report. Curr Pharm Teach Learn. 2025;17(6):102326. https://doi.org/10.1016/j.cptl.2025.102326
  • Mishima Y, Townsend G, Clifton S, Butt A, Vandyck K, Boylan P, Tanaka K. Andexanet-induced heparin resistance in cardiac surgery—a rapid review of case reports and series. J Thromb Haemost. 2025;23(5):1522-1530. https://doi.org/10.1016/j.jtha.2025.01.008
  • Young J, Spisany T, Guidry C, Hong J, Le J, El Rassi E, Boylan P. Dupilumab for chronic obstructive pulmonary disease: a systematic review. Biologics (Basel). 2025;5(1):5. https://doi.org/10.3390/biologics5010005
  • Fleischman ME, Gupta V, McMorris T, Reichmann C, Cone C. Cardiovascular medications: beta-adrenergic blockers. In: King MS, Lipsky MS, eds. Blueprints Family Medicine. 5th ed. Wolters Kluwer Health; 2025:428-432.
  • Ammar A, Edwin S, Whitney R, Lipari M, Giuliano C. Updates in chronic kidney disease management: a systematic review. Pharmacotherapy. 2025;45(5):291-306. https://doi.org/10.1002/phar.70014
  • Santibañez M. Critical care. In: Beckett RD, Bente JA, Bondi DS, et al, eds. Updates in Therapeutics®: Pharmacotherapy Preparatory Review and Recertification Course. American College of Clinical Pharmacy; 2025 (volume 2):295-356.
  • Santibañez M, Rincon-Ponte AM, Sastre Perez G. Antimicrobial stewardship principles for critically ill patients. AACN Adv Crit Care. 2025;36(1):5-13. https://doi.org/10.4037/aacnacc2025715
  • McAfee M, Rettele M, Santibañez M. Tenecteplase reversal in acute ischemic stroke: an overview and case report. 2025;25(1, suppl 12.1):4-6. (Clinical case report for Apr 2025 SCCM Clinical Pharmacy and Pharmacology section newsletter.)
  • Singh-Franco D, Santibañez M, Pham H, Metzner M, Hernandez-Toledo L. Resmetirom for moderate to advanced liver fibrosis. J Nurse Pract. 2025;21(5):105330. https://doi.org/10.1016/j.nurpra.2025.105330

Presentations

  • Paul Boylan: Cannabinoids for sleep. Presented on: The Cannabis Boomer Podcast; August 2025; virtual.
  • Megan Fleischman: Fleischman M, Hall R, Paul L, Abdallah S, Cha-Vang K, Ruffcorn A, Skudlarczyk J, Thomas K, Dalton H. Expansion of collaborative practice in health system specialty pharmacy. Poster presented at: The Pharmacy Society of Wisconsin Educational Conference; April 9, 2025; Madison, WI.
  • Kimmy Nguyen:
    • Complex pharmacotherapy decisions for chronic disease management: diabetes, hypertension, COPD and asthma. Presented at: Advanced Clinical Pharmacology Course for Prescribers through PESI Inc; April 2025; virtual.
    • 7-night advanced pharmacology cruise: treatment strategies for hypertension, diabetes, COPD, GERD, and more. Presented at: Advanced Clinical Pharmacology Course for Prescribers through PESI Inc; March 2025; Fort Lauderdale, FL.
  • Hanna Phan: Childhood stories to grown-up reflections. Presented at: 2025 PPA Annual Conference; April 8-11, 2025; Arlington, VA.
  • Melissa Santibañez:
    • Santibañez M, Carrera S. Systemic steroid dosing practices for acute exacerbations of chronic obstructive pulmonary disease. Research snapshot presented at: SCCM Critical Care Congress; February 2025; Orlando, FL.
    • Santibañez M, Lugo Zamora I, Milicevic L, Maldonado A. Evaluation of clinical outcomes of midodrine on IV vasopressor requirements in critically ill adults. Research snapshot presented at: SCCM Critical Care Congress; February 2025; Orlando, FL.
    • Baggio T, Castellanos A, Del Calvo G, Lybeshari K, Okhovat V, Pham T, Santibañez M. Unmasking the hidden threat: incidence of euglycemic diabetic ketoacidosis with SGLT2 inhibitor therapy. Poster presented at: NSU COP PharmaCon; March 2025; Fort Lauderdale, FL.
    • Gangoo-Dookhan T, Santibañez M, Pham H, et al. Evaluating the impact of a training-based program on social determinants of health for healthcare professionals. Poster presented at: AMCP Annual Meeting; April 2025; Houston, TX.
    • Holder K, Milicevic L, Robainas M, Santibañez M. Impact of nimodipine dosing variation on neurological recovery and cerebral vasospasm incidence. Platform presentation for Florida Residency Conference; May 2025; Tampa, FL.
    • Holder K, Milicevic L, Santibañez M, Robainas M. Impact of nimodipine dosing variation on neurological recovery and cerebral vasospasm incidence. Poster presented at: 12th Annual Memorial Healthcare System Research Week; May 2025; Hollywood, FL.
    • McAfee M, Beyer A, Santibañez M, Milicevic L, Maldonado A. Evaluation of multimodal analgesia in adult trauma critical care patients. Poster presented at: 12th Annual Memorial Healthcare System Research Week; May 2025; Hollywood, FL.

New ACCP Fellows

  • Melissa Lipari

Other Notable Achievements

  • Gary Milavetz:
    • Has resumed role as tenured full professor after stepping down as Executive Associate Dean and Associate Dean of Faculty after 8 years; University of Iowa College of Pharmacy.
    • Delivered Keynote Commencement Address, The University of Minnesota College of Pharmacy graduating class, May 2025.

Transplant PRN

Promotions

  • Sarah Alghanem: Associate Professor, College of Pharmacy of Kuwait University.

 Awards

  • Rita Alloway: 2025 ACCP Paul F. Parker Medal for Distinguished Service to the Profession of Pharmacy.
  • Marie Chisholm-Burns: 2025 ACCP Excellence in Advancement of Diversity, Health Equity, Inclusion, and Accessibility Award.
  • Kellie Goodlet: 2025 Pharmacy Residency Preceptor of the Year, St. Joseph’s Hospital and Medical Center.
  • Karen Khalil: 2024 ACCP Transplant PRN Clinical Practice Award.
  • Alicia Lichvar: 2025 American Society of Transplantation Distinguished Mid-Career Award.
  • Jeong Park: 2024 ACCP Transplant PRN Mentor Award.
  • Lisa Potter: 2025 ACCP C. Edwin Webb Professional Advocacy Award.
  • Helen Sweiss:
    • 2024 ACCP Transplant PRN Junior Investigator Award.
    • 2025 ACCP New Clinical Practitioner Award.

Grants

  • Jeong Park: Predicting Allograft Rejection in Kidney Transplant Recipients Using Plasma Metabolomics and Machine-Learning. University of Michigan College of Pharmacy Stimulus Grant. Co-Investigator ($25,000).

Publications

  • Chan A, Baker WL, Abazia D, Bauman J, DeVane L, Goodlet KJ, et al. Impact of artificial intelligence on future clinical pharmacy research and scholarship. J Am Coll Clin Pharm. 2025;8(4):311-316. https://doi.org/10.1002/jac5.70003
  • Carciofi E, LeCorchick S, Lindberg L, Braun R, Heiman E, Dong L, et al. Single-center outcomes of conversion to belatacept in kidney transplant recipients. Clin Transplant. 2025;39(7):e70220. https://doi.org/10.1111/ctr.70220
  • Rossi A, Katz-Greenberg G, Coscia L, Brady C, Doligalski C, Irani R, et al. Living donation and pregnancy-related complications: state of the evidence and call to action for improved risk assessment. Clin J Am Soc Nephrol. 2024;19(12):1659-1670. https://doi.org/10.2215/CJN.0000000593
  • Mreyoud H, Fitzgerald L, Park JM, Wilpula E, Belloli E, Walter K. Assessment of antimetabolite intolerance in older lung transplant recipients. Prog Transplant. 2025;35(2):110-116. https://doi.org/10.1177/15269248251327419
  • Leino AD, Takyi-Williams J, Park JM, Norman SP, Sun D, Farris KB, et al. Clinical validation of two volumetric absorptive microsampling devices to support home-based therapeutic drug monitoring of immunosuppression after kidney transplantation. Br J Clin Pharmacol. 2024;90(11):2897-2909. https://doi.org/10.1111/bcp.16182
  • Lichvar A, Park JM, Alvey N, Feist A, Pierce DR, Fredrick S, Melaragno JI, Chandran MM, Sweiss HI, Harris M. Association between burnout and workplace climate in transplant clinical pharmacists. Am J Health Syst Pharm. 2025;82(8):435-447. https://doi.org/10.1093/ajhp/zxae306
  • Corello H, Gimferrer I, Perkins J, Kling CE, Henderson M. Positive crossmatch with persistent donor specific antibodies increases risk of rejection in liver transplantation: a retrospective single-center analysis. Hum Immunol. 2025;86(4):111312. https://doi.org/10.1016/j.humimm.2025.111312
  • Strother A, Park JM, Pasternak A. Survey of the utilization of genotype-guided tacrolimus management in the United States solid organ transplant centers. Pharmacogenomics. 2025;26(3-4):89-94. https://doi.org/10.1080/14622416.2025.2489920
  • Walter K, Choksi P, Papaleontiou M, Low Wang C, Gumber R, Park JM. Prescribing practices and barriers to use of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in adult kidney transplant recipients: a survey of endocrinology and nephrology prescribers. J Am Coll Clin Pharm. 2025;8(2):82-90. https://doi.org/10.1002/jac5.2060

Presentations

  • Nicole Alvey: Medication safety during pregnancy and breastfeeding. Invited symposium presentation at: World Transplant Congress; August 2025; San Francisco, CA.
  • Kelsey Coffman: More than numbers: predictors of success in belatacept conversion in kidney transplant recipients. Oral abstract session presented at: World Transplant Congress; August 2025; San Francisco, CA.
  • Barrett Crowther: The evolving role of pharmacists in transplant centers around the globe. Invited symposium presentation at: World Transplant Congress; August 2025; San Francisco, CA.
  • Ashley Feist: Antifungal drug interactions: management pearls. Invited symposium presentation at: World Transplant Congress; August 2025; San Francisco, CA.
  • Kellie Goodlet and Imlay H: Are we the sick police? Examining practicalities of stewardship in immunocompromised hosts. Presented at: The Society for Healthcare Epidemiology of America (SHEA) live webinar; May 2025; virtual.
  • Pham C, Garcia R, Le K, Nailor MD, Goodlet KJ, Tokman S. CYP3A5 genomics-guided tacrolimus dosing in the setting of azole antifungals in lung transplantation. Poster presentation at: World Transplant Congress; August 2025; San Francisco, CA.
  • Tiffany Kaiser: Technology-based adherence tools. Invited symposium presentation at: World Transplant Congress; August 2025; San Francisco, CA.
  • Ann Kataria:
    • TRAMM Tool 2.0: Tips for practice utilization & EMR integration. Invited symposium presentation at: World Transplant Congress; August 2025; San Francisco, CA.
    • Utilizing EHR-integrated proportion of days covered (PDC) to monitor post kidney transplant medication adherence. Oral abstract session presented at: World Transplant Congress; August 2025; San Francisco, CA.
  • Janice Kerr: Too sweet: pharmacy-led post-transplant diabetes management clinic. Invited symposium presentation at: World Transplant Congress; August 2025; San Francisco, CA.
  • Karen Khalil: Dosing of pegcetacoplan with plasmapheresis for treatment of xenoantibody mediated rejection. Oral abstract session presented at: World Transplant Congress; August 2025; San Francisco, CA.
  • Alicia Lichvar: Medical education in the age of AI: skill augmentation or atrophy? Invited symposium presentation at: World Transplant Congress; August 2025; San Francisco, CA.
  • Krysta Walter: Share strategies to implement the newly developed transplant medication adherence videos within your clinical practice. Invited symposium presentation at: World Transplant Congress; August 2025; San Francisco, CA.
  • Allyssa Webb: Extended-release tacrolimus dosing in obese kidney transplant recipients. Oral abstract session presented at: World Transplant Congress; August 2025; San Francisco, CA.
  • Nicole Wilson: Predicting unbound tacrolimus concentrations during pregnancy. Oral abstract session presented at: World Transplant Congress; August 2025; San Francisco, CA.
  • Christine Wolesensky: Improved tacrolimus XR dosing and monitoring outcomes with a genotype-based dosing algorithm vs. weight based dosing. Oral abstract session presented at: World Transplant Congress; August 2025; San Francisco, CA.

New ACCP Fellows

  • Jamie J. Benken
  • Kellie Goodlet
  • Elizabeth Goswani
  • Edward Horn
  • Alicia Lichvar
  • Jennifer McDermott
  • Erin Weeda

Other Notable Achievements

  • Nicole Alvey: Accepted into the ACCP Professional Leadership Development Program (2025-2026 cohort).
  • Kellie Goodlet: Appointed to the editorial advisory board of Open Forum Infectious Diseases, an official journal of the Infectious Diseases Society of America.

Women’s Health PRN

Promotions

  • Lauren Cirrincione: Associate Professor with Tenure, University of Washington.
  • Marina L. Maes: Associate Professor, University of Wisconsin-Madison School of Pharmacy.
  • Veronica Vernon: Chair of Pharmacy Practice, Butler University.

 Awards

  • Marina L. Maes: New Educator Award, American College of Clinical Pharmacy.

 Publications

  • Campbell N, Kalabalik-Hoganson J. Accuracy and teachability of artificial intelligence chatbots in solving pharmaceutical calculations: a descriptive study. Int J Clin Pharm. 2025;47:1109-1113. https://doi.org/10.1007/s11096-025-01947-7
  • Han J, Fang Y, Campbell N. Real-world safety profile of lecanemab: disproportionality analysis of adverse reactions in the FDA Adverse Event Reporting System (FAERS). JAPhA Pharmacother. 2025 May 28. [Epub ahead of print]. https://doi.org/10.1016/j.aphar.2025.100015
  • Cieri-Hutcherson NE, Hutcherson TC, Bradley E, Rizk J, Steele N. Mixed-methods systematic review of pharmacist-administered injectable contraception: insights from patients, pharmacists, and other healthcare professionals. J Am Pharm Assoc (2003). 2025;65(3):102360. https://doi.org/10.1016/j.japh.2025.102360
  • Hutcherson TC, Cieri-Hutcherson NE, Grosshans M, Freemire J, Meegan E, Zu V, et al. Systematic review of intrauterine contraceptive use and the development of toxic shock syndrome. J Pharm Pract. 2025 Jan 8. [Epub ahead of print]. https://doi.org/10.1177/08971900241313402
  • Hutcherson TC, Rowlee P, Abeles J, Cieri-Hutcherson NE. Systematic review of emergency department management of vaso-occlusive episodes in adults with sickle cell disease. J Sick Cell Dis. 2025;2(1):yoaf001. https://doi.org/10.1093/jscdis/yoaf001
  • Winston-McPherson GN, Thomas TA, Krasowski MD, Ahmed SB, Cirrincione LR, Katzman BM, et al. Estradiol concentrations for adequate gender-affirming feminizing therapy: a systematic review. LGBT Health. 2025 Jun 24. [Epub ahead of print]. https://doi.org/10.1089/lgbt.2024.0407
  • Finks SW, Benavides D, Martin AG, Carmon AS. Real-world observations of using compounded GLP-1 ± GIP agonists within a clinical pharmacist-managed cardiometabolic clinic. J Am Coll Clin Pharm. 2025;8(2):91-97. https://doi.org/10.1002/jac5.2071
  • O’Connell MB, DeLellis T. Musculoskeletal and connective tissue. In: Sleeper R, Hutchinson L, eds. Fundamentals of Geriatric Pharmacotherapy: An Evidence-Based Approach. 3rd ed. American Society of Health-System Pharmacists; 2025:483-526.
  • Marcath M, Craig K, O’Connell MB. Impact of reproductive health education seminars on college students’ contraception and safe sex knowledge and behaviors. Pharmacy (Basel). 2025;13(2):39. https://doi.org/10.3390/pharmacy13020039
  • Rowe JM, McBane S, Warner JT, Cirrincione LR. Self-injection experiences among transgender people on injectable gender-affirming hormone therapy: a narrative review. J Am Pharm Assoc (2003). 2025;65(4):102405. https://doi.org/10.1016/j.japh.2025.102405

Presentations

  • Nicole Campbell:
    • Toolkit for contraceptive care: a guide to hormonal contraceptives. Presented at: Seton Hall University College of Nursing’s APN Pharmacology Course; March 2025; Nutley, NJ.
    • Advancing medication safety: key updates from ISMP’s Best Practices 2024-2025. Presented at: 2025 Joint March Conferences presented by NJPHA and GSPO. March 2025; Florham Park, NJ.
  • Brooke Griffin:
    • How women rise: break the 12 habits holding you back from your next raise, promotion, or job. Book Discussion Facilitator. Presented at: AACP, Women in Academia SIG: Luncheon and Business Meeting; July 20, 2025; Chicago, IL.
    • This isn’t bragging: crafting your personal brand and why it matters. Presented at: AACP; July 22, 2025; Chicago, IL.

New ACCP Fellows

  • Nicole Cieri-Hutcherson

Other Notable Achievements

  • Regina Arellano: Invited reviewer for the Sexual and Reproductive Health section within the 2026 Pharmacotherapy Preparatory Review and Recertification Course, American College of Clinical Pharmacy.
  • Lauren Cirrincione: Recognized as a “Top Author of 2024” by the Journal of the American Pharmacists Association for exceptional engagement (eg, citations, online views, and downloads) garnered by the following article: Patterns of psychotropic medication prescribing and potential drug-hormone interactions among transgender and gender-diverse adults within 2 years of hormone therapy. J Am Pharm Assoc (2003). 2024;64(1):283-289.e2. https://doi.org/10.1016/j.japh.2023.10.005
  • Brooke Griffin: Started a podcast: “5 Minute Pep Talk: Mindset, Motivation, and Coaching for Pharmacists.”